CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: cycloalkadiene
Accession: CHEBI:36401
browse the term
Definition: An unsaturated monocyclic hydrocarbon having two endocyclic double bonds.
Synonyms: exact_synonym: cycloalkadienes
G
AATF
apoptosis antagonizing transcription factor
decreases expression
EXP
alpha phellandrene results in decreased expression of AATF mRNA
CTD
PMID:25075043
NCBI chr17:36,948,954...37,056,871
Ensembl chr17:36,948,925...37,056,871
G
ACP1
acid phosphatase 1
decreases expression
EXP
alpha phellandrene results in decreased expression of ACP1 mRNA
CTD
PMID:25075043
NCBI chr 2:264,947...278,283
Ensembl chr 2:264,140...278,283
G
ACSS2
acyl-CoA synthetase short chain family member 2
increases expression
EXP
alpha phellandrene results in increased expression of ACSS2 mRNA
CTD
PMID:25075043
NCBI chr20:34,874,989...34,927,959
Ensembl chr20:34,872,146...34,927,962
G
ADAM18
ADAM metallopeptidase domain 18
decreases expression
EXP
alpha phellandrene results in decreased expression of ADAM18 mRNA
CTD
PMID:25075043
NCBI chr 8:39,584,568...39,730,065
Ensembl chr 8:39,584,489...39,730,065
G
ADAM3A
ADAM metallopeptidase domain 3A (pseudogene)
decreases expression
EXP
alpha phellandrene results in decreased expression of ADAM3 mRNA
CTD
PMID:25075043
NCBI chr 8:39,451,045...39,522,989
Ensembl chr 8:39,451,045...39,522,852 Ensembl chr 8:39,451,045...39,522,852
G
AFG2A
AFG2 AAA ATPase homolog A
decreases expression
EXP
alpha phellandrene results in decreased expression of AFG2A mRNA
CTD
PMID:25075043
NCBI chr 4:122,923,078...123,319,433
Ensembl chr 4:122,923,070...123,319,433
G
AKT1
AKT serine/threonine kinase 1
decreases expression
EXP
alpha phellandrene results in decreased expression of AKT1 protein
CTD
PMID:25649747
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759
G
ALDH1L2
aldehyde dehydrogenase 1 family member L2
increases expression
EXP
alpha phellandrene results in increased expression of ALDH1L2 mRNA
CTD
PMID:25075043
NCBI chr12:105,019,790...105,084,458
Ensembl chr12:105,019,784...105,107,643
G
ALDOC
aldolase, fructose-bisphosphate C
increases expression
EXP
alpha phellandrene results in increased expression of ALDOC mRNA
CTD
PMID:25075043
NCBI chr17:28,573,120...28,576,895
Ensembl chr17:28,573,115...28,576,948
G
ANKRD49
ankyrin repeat domain 49
decreases expression
EXP
alpha phellandrene results in decreased expression of ANKRD49 mRNA
CTD
PMID:25075043
NCBI chr11:94,493,984...94,499,578
Ensembl chr11:94,493,979...94,499,578
G
ANXA1
annexin A1
increases expression
EXP
alpha phellandrene results in increased expression of ANXA1 mRNA
CTD
PMID:25075043
NCBI chr 9:73,151,865...73,170,393
Ensembl chr 9:73,151,865...73,170,629
G
ANXA9
annexin A9
decreases expression
EXP
alpha phellandrene results in decreased expression of ANXA9 mRNA
CTD
PMID:25075043
NCBI chr 1:150,977,306...150,995,634
Ensembl chr 1:150,982,249...150,995,634
G
AP3M2
adaptor related protein complex 3 subunit mu 2
increases expression
EXP
alpha phellandrene results in increased expression of AP3M2 mRNA
CTD
PMID:25075043
NCBI chr 8:42,153,063...42,171,183
Ensembl chr 8:42,152,946...42,171,673
G
ARG2
arginase 2
increases expression
EXP
alpha phellandrene results in increased expression of ARG2 mRNA
CTD
PMID:25075043
NCBI chr14:67,619,920...67,651,708
Ensembl chr14:67,619,920...67,651,708
G
ARHGEF12
Rho guanine nucleotide exchange factor 12
increases expression
EXP
alpha phellandrene results in increased expression of ARHGEF12 mRNA
CTD
PMID:25075043
NCBI chr11:120,336,413...120,489,937
Ensembl chr11:120,336,413...120,489,937
G
ARSK
arylsulfatase family member K
decreases expression
EXP
alpha phellandrene results in decreased expression of ARSK mRNA
CTD
PMID:25075043
NCBI chr 5:95,555,101...95,605,102
Ensembl chr 5:95,555,101...95,605,102
G
ASPA
aspartoacylase
increases expression
EXP
alpha phellandrene results in increased expression of ASPA mRNA
CTD
PMID:25075043
NCBI chr17:3,474,110...3,503,405
Ensembl chr17:3,472,374...3,503,405
G
ATF3
activating transcription factor 3
increases expression
EXP
alpha phellandrene results in increased expression of ATF3 mRNA
CTD
PMID:25075043
NCBI chr 1:212,565,407...212,620,777
Ensembl chr 1:212,565,334...212,620,777
G
BCL2
BCL2 apoptosis regulator
increases phosphorylation
EXP
alpha phellandrene results in increased phosphorylation of BCL2 protein
CTD
PMID:25649747
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
G
BECN1
beclin 1
increases phosphorylation
EXP
alpha phellandrene results in increased phosphorylation of BECN1 protein
CTD
PMID:25649747
NCBI chr17:42,810,132...42,824,282
Ensembl chr17:42,810,134...42,833,350
G
BMF
Bcl2 modifying factor
increases expression
EXP
alpha phellandrene results in increased expression of BMF mRNA
CTD
PMID:25075043
NCBI chr15:40,087,890...40,108,879
Ensembl chr15:40,087,890...40,108,892
G
BNIP3
BCL2 interacting protein 3
increases expression
EXP
alpha phellandrene results in increased expression of BNIP3 mRNA
CTD
PMID:25075043
NCBI chr10:131,967,684...131,981,923
Ensembl chr10:131,967,684...131,981,967
G
BOD1
biorientation of chromosomes in cell division 1
increases expression
EXP
alpha phellandrene results in increased expression of BOD1 mRNA
CTD
PMID:25075043
NCBI chr 5:173,607,145...173,616,650
Ensembl chr 5:173,607,145...173,616,659
G
BRCA1
BRCA1 DNA repair associated
decreases expression
ISO
alpha phellandrene results in decreased expression of BRCA1 protein
CTD
PMID:24861204
NCBI chr17:43,044,295...43,170,327
Ensembl chr17:43,044,295...43,170,245
G
BTG2
BTG anti-proliferation factor 2
increases expression
EXP
alpha phellandrene results in increased expression of BTG2 mRNA
CTD
PMID:25075043
NCBI chr 1:203,305,519...203,309,602
Ensembl chr 1:203,305,491...203,309,602
G
C9orf72
C9orf72-SMCR8 complex subunit
increases expression
EXP
alpha phellandrene results in increased expression of C9ORF72 mRNA
CTD
PMID:25075043
NCBI chr 9:27,546,546...27,573,866
Ensembl chr 9:27,535,640...27,573,866
G
CALM2
calmodulin 2
increases expression
EXP
alpha phellandrene results in increased expression of CALM2 mRNA
CTD
PMID:25075043
NCBI chr 2:47,160,082...47,176,936
Ensembl chr 2:47,160,084...47,176,921
G
CAPNS1
calpain small subunit 1
increases expression
EXP
alpha phellandrene results in increased expression of CAPNS1 mRNA
CTD
PMID:25075043
NCBI chr19:36,140,066...36,150,353
Ensembl chr19:36,139,953...36,150,353
G
CAPRIN2
caprin family member 2
increases expression
EXP
alpha phellandrene results in increased expression of CAPRIN2 mRNA
CTD
PMID:25075043
NCBI chr12:30,709,553...30,754,951
Ensembl chr12:30,709,552...30,823,302
G
CARD6
caspase recruitment domain family member 6
increases expression
EXP
alpha phellandrene results in increased expression of CARD6 mRNA
CTD
PMID:25075043
NCBI chr 5:40,841,367...40,855,354
Ensembl chr 5:40,841,308...40,860,175
G
CARHSP1
calcium regulated heat stable protein 1
increases expression
EXP
alpha phellandrene results in increased expression of CARHSP1 mRNA
CTD
PMID:25075043
NCBI chr16:8,852,942...8,869,006
Ensembl chr16:8,852,942...8,869,012
G
CCL5
C-C motif chemokine ligand 5
increases expression
EXP
alpha phellandrene results in increased expression of CCL5 mRNA
CTD
PMID:25075043
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
G
CCNG2
cyclin G2
increases expression
EXP
alpha phellandrene results in increased expression of CCNG2 mRNA
CTD
PMID:25075043
NCBI chr 4:77,157,207...77,170,060
Ensembl chr 4:77,157,207...77,433,388
G
CCRL2
C-C motif chemokine receptor like 2
increases expression
EXP
alpha phellandrene results in increased expression of CCRL2 mRNA
CTD
PMID:25075043
NCBI chr 3:46,407,259...46,409,523
Ensembl chr 3:46,407,166...46,412,997
G
CD59
CD59 molecule (CD59 blood group)
decreases expression
EXP
alpha phellandrene results in decreased expression of CD59A mRNA
CTD
PMID:25075043
NCBI chr11:33,703,010...33,736,479
Ensembl chr11:33,703,010...33,736,479
G
CDCP2
CUB domain containing protein 2
increases expression
EXP
alpha phellandrene results in increased expression of CDCP2 mRNA
CTD
PMID:25075043
NCBI chr 1:54,132,687...54,153,000
Ensembl chr 1:54,132,687...54,153,770
G
CDKN1A
cyclin dependent kinase inhibitor 1A
increases expression
EXP
alpha phellandrene results in increased expression of CDKN1A mRNA
CTD
PMID:25075043
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,397
G
CDKN2D
cyclin dependent kinase inhibitor 2D
increases expression
EXP
alpha phellandrene results in increased expression of CDKN2D mRNA
CTD
PMID:25075043
NCBI chr19:10,566,460...10,568,979
Ensembl chr19:10,566,460...10,569,059
G
CFLAR
CASP8 and FADD like apoptosis regulator
increases expression
EXP
alpha phellandrene results in increased expression of CFLAR mRNA
CTD
PMID:25075043
NCBI chr 2:201,116,164...201,176,687
Ensembl chr 2:201,116,154...201,176,687
G
CLEC12A
C-type lectin domain family 12 member A
decreases expression
EXP
alpha phellandrene results in decreased expression of CLEC12A mRNA
CTD
PMID:25075043
NCBI chr12:9,951,268...10,006,150
Ensembl chr12:9,951,316...9,995,694
G
CLEC4D
C-type lectin domain family 4 member D
decreases expression
EXP
alpha phellandrene results in decreased expression of CLEC4D mRNA
CTD
PMID:25075043
NCBI chr12:8,513,503...8,531,696
Ensembl chr12:8,509,475...8,522,366
G
CLEC6A
C-type lectin domain containing 6A
decreases expression
EXP
alpha phellandrene results in decreased expression of CLEC4N mRNA
CTD
PMID:25075043
NCBI chr12:8,455,962...8,478,330
Ensembl chr12:8,455,962...8,478,330
G
CLUH
clustered mitochondria homolog
decreases expression
EXP
alpha phellandrene results in decreased expression of CLUH mRNA
CTD
PMID:25075043
NCBI chr17:2,689,387...2,712,020
Ensembl chr17:2,689,386...2,712,663
G
CMPK2
cytidine/uridine monophosphate kinase 2
increases expression
EXP
alpha phellandrene results in increased expression of CMPK2 mRNA
CTD
PMID:25075043
NCBI chr 2:6,840,553...6,866,635
Ensembl chr 2:6,840,570...6,866,635
G
CR1L
complement C3b/C4b receptor 1 like
decreases expression
EXP
alpha phellandrene results in decreased expression of CR1L mRNA
CTD
PMID:25075043
NCBI chr 1:207,645,133...207,723,703
Ensembl chr 1:207,645,113...207,738,416
G
CRISP1
cysteine rich secretory protein 1
decreases expression
EXP
alpha phellandrene results in decreased expression of CRISP1 mRNA
CTD
PMID:25075043
NCBI chr 6:49,834,257...49,877,096
Ensembl chr 6:49,834,257...49,877,096
G
CST7
cystatin F
decreases expression
EXP
alpha phellandrene results in decreased expression of CST7 mRNA
CTD
PMID:25075043
NCBI chr20:24,949,269...24,959,928
Ensembl chr20:24,949,269...24,959,928
G
CSTA
cystatin A
increases expression
EXP
alpha phellandrene results in increased expression of STFA1 mRNA
CTD
PMID:25075043
NCBI chr 3:122,325,248...122,341,969
Ensembl chr 3:122,325,248...122,341,969
G
CTSG
cathepsin G
decreases expression
EXP
alpha phellandrene results in decreased expression of CTSG mRNA
CTD
PMID:25075043
NCBI chr14:24,573,518...24,576,250
Ensembl chr14:24,573,518...24,576,250
G
CXCL10
C-X-C motif chemokine ligand 10
increases expression
EXP
alpha phellandrene results in increased expression of CXCL10 mRNA
CTD
PMID:25075043
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
G
CYB561D2
cytochrome b561 family member D2
decreases expression
EXP
alpha phellandrene results in decreased expression of CYB561D2 mRNA
CTD
PMID:25075043
NCBI chr 3:50,350,862...50,354,069
Ensembl chr 3:50,350,845...50,358,460
G
CYFIP2
cytoplasmic FMR1 interacting protein 2
increases expression
EXP
alpha phellandrene results in increased expression of CYFIP2 mRNA
CTD
PMID:25075043
NCBI chr 5:157,266,123...157,395,594
Ensembl chr 5:157,266,079...157,395,595
G
CYP51A1
cytochrome P450 family 51 subfamily A member 1
decreases expression
EXP
alpha phellandrene results in decreased expression of CYP51 mRNA
CTD
PMID:25075043
NCBI chr 7:92,112,153...92,134,803
Ensembl chr 7:92,084,987...92,134,803
G
DBX1
developing brain homeobox 1
increases expression
EXP
alpha phellandrene results in increased expression of DBX1 mRNA
CTD
PMID:25075043
NCBI chr11:20,156,155...20,160,475
Ensembl chr11:20,156,155...20,160,475
G
DCTD
dCMP deaminase
decreases expression
EXP
alpha phellandrene results in decreased expression of DCTD mRNA
CTD
PMID:25075043
NCBI chr 4:182,890,091...182,917,611
Ensembl chr 4:182,890,060...182,917,936
G
DDIT4
DNA damage inducible transcript 4
increases expression
EXP
alpha phellandrene results in increased expression of DDIT4 mRNA
CTD
PMID:25075043
NCBI chr10:72,273,924...72,276,036
Ensembl chr10:72,273,919...72,276,036
G
DDX31
DEAD-box helicase 31
decreases expression
EXP
alpha phellandrene results in decreased expression of DDX31 mRNA
CTD
PMID:25075043
NCBI chr 9:132,592,997...132,669,983
Ensembl chr 9:132,592,997...132,670,401
G
DDX60
DExD/H-box helicase 60
increases expression
EXP
alpha phellandrene results in increased expression of DDX60 mRNA
CTD
PMID:25075043
NCBI chr 4:168,216,294...168,325,979
Ensembl chr 4:168,216,291...168,318,883
G
DFFB
DNA fragmentation factor subunit beta
increases expression
EXP
alpha phellandrene results in increased expression of DFFB mRNA
CTD
PMID:25075043
NCBI chr 1:3,857,476...3,885,429
Ensembl chr 1:3,857,267...3,885,429
G
DGKA
diacylglycerol kinase alpha
increases expression
EXP
alpha phellandrene results in increased expression of DGKA mRNA
CTD
PMID:25075043
NCBI chr12:55,927,316...55,954,023
Ensembl chr12:55,927,319...55,954,027
G
DHRS1
dehydrogenase/reductase 1
increases expression
EXP
alpha phellandrene results in increased expression of DHRS1 mRNA
CTD
PMID:25075043
NCBI chr14:24,290,598...24,299,780
Ensembl chr14:24,290,598...24,299,780
G
DHX33
DEAH-box helicase 33
decreases expression
EXP
alpha phellandrene results in decreased expression of DHX33 mRNA
CTD
PMID:25075043
NCBI chr17:5,440,917...5,468,982
Ensembl chr17:5,440,917...5,468,982
G
DHX58
DExH-box helicase 58
increases expression
EXP
alpha phellandrene results in increased expression of DHX58 mRNA
CTD
PMID:25075043
NCBI chr17:42,101,411...42,112,714
Ensembl chr17:42,101,404...42,112,714
G
DKC1
dyskerin pseudouridine synthase 1
decreases expression
EXP
alpha phellandrene results in decreased expression of DKC1 mRNA
CTD
PMID:25075043
NCBI chr X:154,762,864...154,777,689
Ensembl chr X:154,762,742...154,777,689
G
DUSP1
dual specificity phosphatase 1
increases expression
EXP
alpha phellandrene results in increased expression of DUSP1 mRNA
CTD
PMID:25075043
NCBI chr 5:172,768,096...172,771,195
Ensembl chr 5:172,768,096...172,771,195
G
DUSP6
dual specificity phosphatase 6
increases expression
EXP
alpha phellandrene results in increased expression of DUSP6 mRNA
CTD
PMID:25075043
NCBI chr12:89,347,235...89,352,501
Ensembl chr12:89,347,235...89,352,501
G
DYNLT3
dynein light chain Tctex-type 3
increases expression
EXP
alpha phellandrene results in increased expression of DYNLT3 mRNA
CTD
PMID:25075043
NCBI chr X:37,838,836...37,847,571
Ensembl chr X:37,836,757...37,847,571
G
EGLN3
egl-9 family hypoxia inducible factor 3
increases expression
EXP
alpha phellandrene results in increased expression of EGLN3 mRNA
CTD
PMID:25075043
NCBI chr14:33,924,227...33,951,074
Ensembl chr14:33,924,227...34,462,774
G
EGR1
early growth response 1
increases expression
EXP
alpha phellandrene results in increased expression of EGR1 mRNA
CTD
PMID:25075043
NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
G
EIF5
eukaryotic translation initiation factor 5
decreases expression
EXP
alpha phellandrene results in decreased expression of EIF5 mRNA
CTD
PMID:25075043
NCBI chr14:103,334,237...103,345,025
Ensembl chr14:103,333,544...103,345,025
G
ELAC2
elaC ribonuclease Z 2
decreases expression
EXP
alpha phellandrene results in decreased expression of ELAC2 mRNA
CTD
PMID:25075043
NCBI chr17:12,991,612...13,018,027
Ensembl chr17:12,991,612...13,018,065
G
ELOVL1
ELOVL fatty acid elongase 1
decreases expression
EXP
alpha phellandrene results in decreased expression of ELOVL1 mRNA
CTD
PMID:25075043
NCBI chr 1:43,363,401...43,368,011
Ensembl chr 1:43,363,398...43,368,074
G
ELOVL7
ELOVL fatty acid elongase 7
increases expression
EXP
alpha phellandrene results in increased expression of ELOVL7 mRNA
CTD
PMID:25075043
NCBI chr 5:60,751,791...60,844,269
Ensembl chr 5:60,751,791...60,844,274
G
ENO2
enolase 2
increases expression
EXP
alpha phellandrene results in increased expression of ENO2 mRNA
CTD
PMID:25075043
NCBI chr12:6,914,580...6,923,697
Ensembl chr12:6,913,745...6,923,698
G
FBXO44
F-box protein 44
increases expression
EXP
alpha phellandrene results in increased expression of FBXO44 mRNA
CTD
PMID:25075043
NCBI chr 1:11,654,407...11,663,327
Ensembl chr 1:11,654,375...11,663,327
G
FGGY
FGGY carbohydrate kinase domain containing
increases expression
EXP
alpha phellandrene results in increased expression of FGGY mRNA
CTD
PMID:25075043
NCBI chr 1:59,296,378...59,762,730
Ensembl chr 1:59,296,638...59,810,647
G
FLVCR1
FLVCR choline and heme transporter 1
decreases expression
EXP
alpha phellandrene results in decreased expression of FLVCR1 mRNA
CTD
PMID:25075043
NCBI chr 1:212,858,275...212,899,363
Ensembl chr 1:212,858,275...212,899,363
G
FOS
Fos proto-oncogene, AP-1 transcription factor subunit
increases expression
EXP
alpha phellandrene results in increased expression of FOS mRNA
CTD
PMID:25075043
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,283,190
G
FOXO1
forkhead box O1
increases expression
EXP
alpha phellandrene results in increased expression of FOXO1 mRNA
CTD
PMID:25075043
NCBI chr13:40,555,667...40,666,641
Ensembl chr13:40,555,667...40,666,641
G
FPR1
formyl peptide receptor 1
decreases expression
EXP
alpha phellandrene results in decreased expression of FPR1 mRNA
CTD
PMID:25075043
NCBI chr19:51,745,172...51,751,878
Ensembl chr19:51,745,172...51,804,115
G
FTH1
ferritin heavy chain 1
increases expression
EXP
alpha phellandrene results in increased expression of FTH1 mRNA
CTD
PMID:25075043
NCBI chr11:61,964,285...61,967,634
Ensembl chr11:61,959,718...61,967,634
G
FTL
ferritin light chain
increases expression
EXP
alpha phellandrene results in increased expression of FTL1 mRNA; alpha phellandrene results in increased expression of FTL2-PS mRNA
CTD
PMID:25075043
NCBI chr19:48,965,309...48,966,879
Ensembl chr19:48,965,309...48,967,896
G
FTSJ3
FtsJ RNA 2'-O-methyltransferase 3
decreases expression
EXP
alpha phellandrene results in decreased expression of FTSJ3 mRNA
CTD
PMID:25075043
NCBI chr17:63,819,433...63,827,663
Ensembl chr17:63,819,433...63,830,012
G
FXN
frataxin
decreases expression
EXP
alpha phellandrene results in decreased expression of FXN mRNA
CTD
PMID:25075043
NCBI chr 9:69,035,752...69,079,076
Ensembl chr 9:69,035,751...69,079,076
G
GABARAP
GABA type A receptor-associated protein
increases expression
EXP
alpha phellandrene results in increased expression of GABARAP mRNA
CTD
PMID:25075043
NCBI chr17:7,240,008...7,242,449
Ensembl chr17:7,240,008...7,242,449
G
GADD45A
growth arrest and DNA damage inducible alpha
increases expression
EXP
alpha phellandrene results in increased expression of GADD45A mRNA
CTD
PMID:25075043
NCBI chr 1:67,685,201...67,688,334
Ensembl chr 1:67,685,201...67,688,334
G
GAS5
growth arrest specific 5
decreases expression
EXP
alpha phellandrene results in decreased expression of GAS5 mRNA
CTD
PMID:25075043
NCBI chr 1:173,863,901...173,869,045
Ensembl chr 1:173,851,424...173,868,940
G
GBP6
guanylate binding protein family member 6
increases expression
EXP
alpha phellandrene results in increased expression of GBP6 mRNA
CTD
PMID:25075043
NCBI chr 1:89,364,059...89,388,160
Ensembl chr 1:89,364,059...89,388,160
G
GNAS
GNAS complex locus
increases expression
EXP
alpha phellandrene results in increased expression of GNAS mRNA
CTD
PMID:25075043
NCBI chr20:58,839,748...58,911,192
Ensembl chr20:58,839,718...58,911,192
G
GNL3
G protein nucleolar 3
decreases expression
EXP
alpha phellandrene results in decreased expression of GNL3 mRNA
CTD
PMID:25075043
NCBI chr 3:52,685,920...52,694,497
Ensembl chr 3:52,681,156...52,694,497
G
GPR84
G protein-coupled receptor 84
decreases expression
EXP
alpha phellandrene results in decreased expression of GPR84 mRNA
CTD
PMID:25075043
NCBI chr12:54,350,698...54,364,486
Ensembl chr12:54,362,445...54,364,487
G
GREB1L
GREB1 like retinoic acid receptor coactivator
increases expression
EXP
alpha phellandrene results in increased expression of GREB1L mRNA
CTD
PMID:25075043
NCBI chr18:21,242,232...21,526,112
Ensembl chr18:21,242,232...21,526,112
G
GRINA
glutamate ionotropic receptor NMDA type subunit associated protein 1
increases expression
EXP
alpha phellandrene results in increased expression of GRINA mRNA
CTD
PMID:25075043
NCBI chr 8:143,990,056...143,993,415
Ensembl chr 8:143,990,056...143,993,415
G
GTDC1
glycosyltransferase like domain containing 1
increases expression
EXP
alpha phellandrene results in increased expression of GTDC1 mRNA
CTD
PMID:25075043
NCBI chr 2:143,938,068...144,333,069
Ensembl chr 2:143,938,068...144,332,568
G
GYS1
glycogen synthase 1
increases expression
EXP
alpha phellandrene results in increased expression of GYS1 mRNA
CTD
PMID:25075043
NCBI chr19:48,968,130...48,993,309
Ensembl chr19:48,968,130...48,993,310
G
GZMH
granzyme H
decreases expression
EXP
alpha phellandrene results in decreased expression of GZME mRNA
CTD
PMID:25075043
NCBI chr14:24,606,480...24,609,685
Ensembl chr14:24,606,480...24,609,699
G
H1-0
H1.0 linker histone
increases expression
EXP
alpha phellandrene results in increased expression of H1F0 mRNA
CTD
PMID:25075043
NCBI chr22:37,805,229...37,807,432
Ensembl chr22:37,805,229...37,807,432
G
H1-2
H1.2 linker histone, cluster member
increases expression
EXP
alpha phellandrene results in increased expression of H1F2 mRNA
CTD
PMID:25075043
NCBI chr 6:26,055,740...26,056,470
Ensembl chr 6:26,054,760...26,056,470
G
H2BC14
H2B clustered histone 14
increases expression
EXP
alpha phellandrene results in increased expression of H2BC14 mRNA
CTD
PMID:25075043
NCBI chr 6:27,815,022...27,815,489
Ensembl chr 6:27,815,022...27,815,489
G
H2BC18
H2B clustered histone 18
increases expression
EXP
alpha phellandrene results in increased expression of H2BC18 mRNA
CTD
PMID:25075043
NCBI chr 1:149,782,689...149,812,370
Ensembl chr 1:149,782,689...149,812,373
G
H2BC4
H2B clustered histone 4
increases expression
EXP
alpha phellandrene results in increased expression of H2BC4 mRNA
CTD
PMID:25075043
NCBI chr 6:26,113,170...26,123,926
Ensembl chr 6:26,086,317...26,123,926
G
H3C4
H3 clustered histone 4
increases expression
EXP
alpha phellandrene results in increased expression of H3C4 mRNA
CTD
PMID:25075043
NCBI chr 6:26,196,784...26,199,293
Ensembl chr 6:26,195,164...26,197,286
G
H4C4
H4 clustered histone 4
increases expression
EXP
alpha phellandrene results in increased expression of H4C4 mRNA
CTD
PMID:25075043
NCBI chr 6:26,188,710...26,189,112
Ensembl chr 6:26,188,710...26,189,112
G
HCAR2
hydroxycarboxylic acid receptor 2
increases expression
EXP
alpha phellandrene results in increased expression of HCAR2 mRNA
CTD
PMID:25075043
NCBI chr12:122,701,293...122,703,357
Ensembl chr12:122,701,293...122,703,357
G
HEATR1
HEAT repeat containing 1
decreases expression
EXP
alpha phellandrene results in decreased expression of HEATR1 mRNA
CTD
PMID:25075043
NCBI chr 1:236,549,005...236,604,516
Ensembl chr 1:236,549,005...236,604,516
G
HELZ2
helicase with zinc finger 2
increases expression
EXP
alpha phellandrene results in increased expression of HELZ2 mRNA
CTD
PMID:25075043
NCBI chr20:63,558,086...63,574,239
Ensembl chr20:63,558,086...63,574,239
G
HGH1
HGH1 homolog
decreases expression
EXP
alpha phellandrene results in decreased expression of BRP16 mRNA
CTD
PMID:25075043
NCBI chr 8:144,137,774...144,140,851
Ensembl chr 8:144,137,774...144,140,851
G
HILPDA
hypoxia inducible lipid droplet associated
increases expression
EXP
alpha phellandrene results in increased expression of HILPDA mRNA
CTD
PMID:25075043
NCBI chr 7:128,455,878...128,458,418
Ensembl chr 7:128,455,849...128,458,418
G
HIVEP3
HIVEP zinc finger 3
increases expression
EXP
alpha phellandrene results in increased expression of HIVEP3 mRNA
CTD
PMID:25075043
NCBI chr 1:41,506,365...42,035,934
Ensembl chr 1:41,506,365...42,035,925
G
HSPA2
heat shock protein family A (Hsp70) member 2
increases expression
EXP
alpha phellandrene results in increased expression of HSPA2 mRNA
CTD
PMID:25075043
NCBI chr14:64,535,905...64,543,237
Ensembl chr14:64,535,905...64,546,173
G
HSPA5
heat shock protein family A (Hsp70) member 5
decreases expression
EXP
alpha phellandrene results in decreased expression of HSPA5 mRNA
CTD
PMID:25075043
NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382
G
HSPA8
heat shock protein family A (Hsp70) member 8
decreases expression
EXP
alpha phellandrene results in decreased expression of HSPA8 mRNA
CTD
PMID:25075043
NCBI chr11:123,057,489...123,062,462
Ensembl chr11:123,057,489...123,063,230
G
ID2
inhibitor of DNA binding 2
increases expression
EXP
alpha phellandrene results in increased expression of ID2 mRNA
CTD
PMID:25075043
NCBI chr 2:8,682,056...8,684,461
Ensembl chr 2:8,678,845...8,684,461
G
IDI1
isopentenyl-diphosphate delta isomerase 1
decreases expression
EXP
alpha phellandrene results in decreased expression of IDI1 mRNA
CTD
PMID:25075043
NCBI chr10:1,039,152...1,056,704
Ensembl chr10:1,039,152...1,049,119
G
IFIH1
interferon induced with helicase C domain 1
increases expression
EXP
alpha phellandrene results in increased expression of IFIH1 mRNA
CTD
PMID:25075043
NCBI chr 2:162,267,074...162,318,684
Ensembl chr 2:162,267,074...162,318,684
G
IFIT1
interferon induced protein with tetratricopeptide repeats 1
increases expression
EXP
alpha phellandrene results in increased expression of IFIT1 mRNA
CTD
PMID:25075043
NCBI chr10:89,392,623...89,406,487
Ensembl chr10:89,392,546...89,406,487
G
IFNL3
interferon lambda 3
increases expression
EXP
alpha phellandrene results in increased expression of IFNL3 mRNA
CTD
PMID:25075043
NCBI chr19:39,243,455...39,245,250
Ensembl chr19:39,243,455...39,245,250
G
IL2RA
interleukin 2 receptor subunit alpha
decreases expression
EXP
alpha phellandrene results in decreased expression of IL2RA mRNA
CTD
PMID:25075043
NCBI chr10:6,010,689...6,062,367
Ensembl chr10:6,010,689...6,062,370
G
IL36G
interleukin 36 gamma
decreases expression
EXP
alpha phellandrene results in decreased expression of IL36G mRNA
CTD
PMID:25075043
NCBI chr 2:112,978,006...112,985,658
Ensembl chr 2:112,973,203...112,985,658
G
IRF5
interferon regulatory factor 5
increases expression
EXP
alpha phellandrene results in increased expression of IRF5 mRNA
CTD
PMID:25075043
NCBI chr 7:128,937,032...128,950,038
Ensembl chr 7:128,937,457...128,950,038
G
IRF7
interferon regulatory factor 7
increases expression
EXP
alpha phellandrene results in increased expression of IRF7 mRNA
CTD
PMID:25075043
NCBI chr11:612,555...615,950
Ensembl chr11:612,553...615,983
G
IRGM
immunity related GTPase M
increases expression
EXP
alpha phellandrene results in increased expression of IRGM2 mRNA
CTD
PMID:25075043
NCBI chr 5:150,846,521...150,902,402
Ensembl chr 5:150,846,521...150,900,736
G
ITGAL
integrin subunit alpha L
increases expression
EXP
alpha phellandrene results in increased expression of ITGAL mRNA
CTD
PMID:25075043
NCBI chr16:30,472,742...30,523,185
Ensembl chr16:30,472,658...30,523,567
G
JAGN1
jagunal homolog 1
decreases expression
EXP
alpha phellandrene results in decreased expression of JAGN1 mRNA
CTD
PMID:25075043
NCBI chr 3:9,890,610...9,894,349
Ensembl chr 3:9,890,574...9,894,349
G
JUN
Jun proto-oncogene, AP-1 transcription factor subunit
increases expression
EXP
alpha phellandrene results in increased expression of JUN mRNA
CTD
PMID:25075043
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
G
KANK2
KN motif and ankyrin repeat domains 2
decreases expression
EXP
alpha phellandrene results in decreased expression of KANK2 mRNA
CTD
PMID:25075043
NCBI chr19:11,164,270...11,197,865
Ensembl chr19:11,164,270...11,197,791
G
KDM7A
lysine demethylase 7A
increases expression
EXP
alpha phellandrene results in increased expression of KDM7A mRNA
CTD
PMID:25075043
NCBI chr 7:140,084,746...140,176,983
Ensembl chr 7:140,084,746...140,176,983
G
KLHL23
kelch like family member 23
increases expression
EXP
alpha phellandrene results in increased expression of KLHL23 mRNA
CTD
PMID:25075043
NCBI chr 2:169,733,832...169,751,878
Ensembl chr 2:169,694,488...169,776,989
G
KLHL24
kelch like family member 24
increases expression
EXP
alpha phellandrene results in increased expression of KLHL24 mRNA
CTD
PMID:25075043
NCBI chr 3:183,635,623...183,684,519
Ensembl chr 3:183,635,610...183,684,519
G
LIMA1
LIM domain and actin binding 1
increases expression
EXP
alpha phellandrene results in increased expression of LIMA1 mRNA
CTD
PMID:25075043
NCBI chr12:50,175,788...50,283,520
Ensembl chr12:50,175,788...50,283,520
G
LLGL2
LLGL scribble cell polarity complex component 2
decreases expression
EXP
alpha phellandrene results in decreased expression of LLGL2 mRNA
CTD
PMID:25075043
NCBI chr17:75,525,002...75,575,209
Ensembl chr17:75,525,080...75,575,209
G
LPP
LIM domain containing preferred translocation partner in lipoma
increases expression
EXP
alpha phellandrene results in increased expression of LPP mRNA
CTD
PMID:25075043
NCBI chr 3:188,153,021...188,890,671
Ensembl chr 3:188,153,284...188,890,671
G
LTN1
listerin E3 ubiquitin protein ligase 1
decreases expression
EXP
alpha phellandrene results in decreased expression of LTN1 mRNA
CTD
PMID:25075043
NCBI chr21:28,928,144...28,992,877
Ensembl chr21:28,928,144...28,992,956
G
LY6H
lymphocyte antigen 6 family member H
decreases expression
EXP
alpha phellandrene results in decreased expression of LY6C1 mRNA; alpha phellandrene results in decreased expression of LY6C2 mRNA
CTD
PMID:25075043
NCBI chr 8:143,157,916...143,160,654
Ensembl chr 8:143,157,914...143,160,711
G
MAP2K6
mitogen-activated protein kinase kinase 6
increases expression
EXP
alpha phellandrene results in increased expression of MAP2K6 mRNA
CTD
PMID:25075043
NCBI chr17:69,414,697...69,553,865
Ensembl chr17:69,414,697...69,553,865
G
MAT2A
methionine adenosyltransferase 2A
decreases expression
EXP
alpha phellandrene results in decreased expression of MAT2A mRNA
CTD
PMID:25075043
NCBI chr 2:85,539,168...85,545,281
Ensembl chr 2:85,539,168...85,545,281
G
MCEMP1
mast cell expressed membrane protein 1
increases expression
EXP
alpha phellandrene results in increased expression of MCEMP1 mRNA
CTD
PMID:25075043
NCBI chr19:7,677,090...7,679,829
Ensembl chr19:7,677,088...7,679,829
G
MDC1
mediator of DNA damage checkpoint 1
increases expression
ISO
alpha phellandrene results in increased expression of MDC1 protein
CTD
PMID:24861204
NCBI chr 6:30,699,807...30,717,281
Ensembl chr 6:30,699,807...30,717,447
G
MDN1
midasin AAA ATPase 1
decreases expression
EXP
alpha phellandrene results in decreased expression of MDN1 mRNA
CTD
PMID:25075043
NCBI chr 6:89,642,498...89,819,794
Ensembl chr 6:89,642,498...89,819,794
G
MED29
mediator complex subunit 29
decreases expression
EXP
alpha phellandrene results in decreased expression of MED29 mRNA
CTD
PMID:25075043
NCBI chr19:39,391,378...39,400,641
Ensembl chr19:39,391,303...39,400,641
G
MED31
mediator complex subunit 31
increases expression
EXP
alpha phellandrene results in increased expression of MED31 mRNA
CTD
PMID:25075043
NCBI chr17:6,643,311...6,651,605
Ensembl chr17:6,643,311...6,651,634
G
MGARP
mitochondria localized glutamic acid rich protein
increases expression
EXP
alpha phellandrene results in increased expression of MGARP mRNA
CTD
PMID:25075043
NCBI chr 4:139,266,165...139,280,225
Ensembl chr 4:139,266,165...139,280,225
G
MGAT2
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase
decreases expression
EXP
alpha phellandrene results in decreased expression of MGAT2 mRNA
CTD
PMID:25075043
NCBI chr14:49,620,799...49,623,481
Ensembl chr14:49,620,799...49,623,481
G
MGMT
O-6-methylguanine-DNA methyltransferase
decreases expression
ISO
alpha phellandrene results in decreased expression of MGMT protein
CTD
PMID:24861204
NCBI chr10:129,467,241...129,770,983
Ensembl chr10:129,467,190...129,770,983
G
MINDY2
MINDY lysine 48 deubiquitinase 2
increases expression
EXP
alpha phellandrene results in increased expression of MINDY2 mRNA
CTD
PMID:25075043
NCBI chr15:58,771,302...58,861,900
Ensembl chr15:58,771,192...58,861,900
G
MIR17HG
miR-17-92a-1 cluster host gene
decreases expression
EXP
alpha phellandrene results in decreased expression of MIR17HG mRNA
CTD
PMID:25075043
NCBI chr13:91,347,687...91,354,577
Ensembl chr13:91,347,686...91,397,592
G
MIR375
microRNA 375
increases expression
EXP
alpha phellandrene results in increased expression of MIR375 mRNA
CTD
PMID:25075043
NCBI chr 2:219,001,645...219,001,708
Ensembl chr 2:219,001,645...219,001,708
G
MR1
major histocompatibility complex, class I-related
increases expression
EXP
alpha phellandrene results in increased expression of MR1 mRNA
CTD
PMID:25075043
NCBI chr 1:181,033,387...181,061,938
Ensembl chr 1:181,033,374...181,061,938
G
MRPL20
mitochondrial ribosomal protein L20
decreases expression
EXP
alpha phellandrene results in decreased expression of MRPL20 mRNA
CTD
PMID:25075043
NCBI chr 1:1,401,909...1,407,293
Ensembl chr 1:1,401,909...1,407,293
G
MRPL45
mitochondrial ribosomal protein L45
increases expression
EXP
alpha phellandrene results in increased expression of MRPL45 mRNA
CTD
PMID:25075043
NCBI chr17:38,297,168...38,323,211
Ensembl chr17:38,297,023...38,323,217
G
MRTO4
MRT4 homolog, ribosome maturation factor
decreases expression
EXP
alpha phellandrene results in decreased expression of MRTO4 mRNA
CTD
PMID:25075043
NCBI chr 1:19,251,805...19,260,128
Ensembl chr 1:19,251,805...19,260,128
G
MS4A3
membrane spanning 4-domains A3
decreases expression
EXP
alpha phellandrene results in decreased expression of MS4A3 mRNA
CTD
PMID:25075043
NCBI chr11:60,056,665...60,071,115
Ensembl chr11:60,056,587...60,071,115
G
MTOR
mechanistic target of rapamycin kinase
decreases expression
EXP
alpha phellandrene results in decreased expression of MTOR protein
CTD
PMID:25649747
NCBI chr 1:11,106,535...11,262,551
Ensembl chr 1:11,106,535...11,262,556
G
MTX3
metaxin 3
decreases expression
EXP
alpha phellandrene results in decreased expression of MTX3 mRNA
CTD
PMID:25075043
NCBI chr 5:79,976,716...79,991,262
Ensembl chr 5:79,976,716...79,991,262
G
MUC13
mucin 13, cell surface associated
decreases expression
EXP
alpha phellandrene results in decreased expression of MUC13 mRNA
CTD
PMID:25075043
NCBI chr 3:124,905,442...124,934,751
Ensembl chr 3:124,905,442...124,953,819
G
MX2
MX dynamin like GTPase 2
increases expression
EXP
alpha phellandrene results in increased expression of MX2 mRNA
CTD
PMID:25075043
NCBI chr21:41,362,027...41,409,393
Ensembl chr21:41,361,999...41,409,393
G
MXD1
MAX dimerization protein 1
increases expression
EXP
alpha phellandrene results in increased expression of MXD1 mRNA
CTD
PMID:25075043
NCBI chr 2:69,915,109...69,942,945
Ensembl chr 2:69,897,688...69,942,945
G
MYADM
myeloid associated differentiation marker
increases expression
EXP
alpha phellandrene results in increased expression of MYADM mRNA
CTD
PMID:25075043
NCBI chr19:53,865,628...53,876,435
Ensembl chr19:53,864,763...53,878,125
G
MYBBP1A
MYB binding protein 1a
decreases expression
EXP
alpha phellandrene results in decreased expression of MYBBP1A mRNA
CTD
PMID:25075043
NCBI chr17:4,538,904...4,555,384
Ensembl chr17:4,538,897...4,555,386
G
MYO9A
myosin IXA
increases expression
EXP
alpha phellandrene results in increased expression of MYO9A mRNA
CTD
PMID:25075043
NCBI chr15:71,822,291...72,118,600
Ensembl chr15:71,822,291...72,118,577
G
NAMPT
nicotinamide phosphoribosyltransferase
increases expression
EXP
alpha phellandrene results in increased expression of NAMPT mRNA
CTD
PMID:25075043
NCBI chr 7:106,248,298...106,285,888
Ensembl chr 7:106,248,298...106,285,966
G
NAT10
N-acetyltransferase 10
decreases expression
EXP
alpha phellandrene results in decreased expression of NAT10 mRNA
CTD
PMID:25075043
NCBI chr11:34,105,629...34,146,908
Ensembl chr11:34,105,617...34,147,670
G
NDRG2
NDRG family member 2
increases expression
EXP
alpha phellandrene results in increased expression of NDRG2 mRNA
CTD
PMID:25075043
NCBI chr14:21,016,763...21,070,872
Ensembl chr14:21,016,763...21,070,872
G
NFIL3
nuclear factor, interleukin 3 regulated
increases expression
EXP
alpha phellandrene results in increased expression of NFIL3 mRNA
CTD
PMID:25075043
NCBI chr 9:91,409,045...91,483,497
Ensembl chr 9:91,408,748...91,424,626
G
NFKBIA
NFKB inhibitor alpha
increases expression
EXP
alpha phellandrene results in increased expression of NFKBIA mRNA
CTD
PMID:25075043
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
G
NHP2
NHP2 ribonucleoprotein
decreases expression
EXP
alpha phellandrene results in decreased expression of NHP2 mRNA
CTD
PMID:25075043
NCBI chr 5:178,149,463...178,153,885
Ensembl chr 5:178,149,463...178,153,894
G
NOL10
nucleolar protein 10
decreases expression
EXP
alpha phellandrene results in decreased expression of NOL10 mRNA
CTD
PMID:25075043
NCBI chr 2:10,570,754...10,689,975
Ensembl chr 2:10,562,347...10,689,987
G
NOL8
nucleolar protein 8
decreases expression
EXP
alpha phellandrene results in decreased expression of NOL8 mRNA
CTD
PMID:25075043
NCBI chr 9:92,297,358...92,325,350
Ensembl chr 9:92,297,358...92,325,636
G
NOLC1
nucleolar and coiled-body phosphoprotein 1
decreases expression
EXP
alpha phellandrene results in decreased expression of NOLC1 mRNA
CTD
PMID:25075043
NCBI chr10:102,152,389...102,163,870
Ensembl chr10:102,152,176...102,163,871
G
NOP2
NOP2 nucleolar protein
decreases expression
EXP
alpha phellandrene results in decreased expression of NOP2 mRNA
CTD
PMID:25075043
NCBI chr12:6,556,871...6,568,291
Ensembl chr12:6,556,863...6,568,691
G
NOP56
NOP56 ribonucleoprotein
decreases expression
EXP
alpha phellandrene results in decreased expression of NOP56 mRNA
CTD
PMID:25075043
NCBI chr20:2,652,632...2,658,393
Ensembl chr20:2,652,593...2,658,393
G
NOS2
nitric oxide synthase 2
increases expression
EXP
alpha phellandrene results in increased expression of NOS2 mRNA
CTD
PMID:25075043
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
NXT2
nuclear transport factor 2 like export factor 2
increases expression
EXP
alpha phellandrene results in increased expression of NXT2 mRNA
CTD
PMID:25075043
NCBI chr X:109,535,824...109,544,698
Ensembl chr X:109,535,781...109,544,698
G
OAS1
2'-5'-oligoadenylate synthetase 1
increases expression
EXP
alpha phellandrene results in increased expression of OAS1A mRNA; alpha phellandrene results in increased expression of OAS1B mRNA
CTD
PMID:25075043
NCBI chr12:112,906,962...112,933,219
Ensembl chr12:112,905,856...112,933,219
G
OAS3
2'-5'-oligoadenylate synthetase 3
increases expression
EXP
alpha phellandrene results in increased expression of OAS3 mRNA
CTD
PMID:25075043
NCBI chr12:112,938,474...112,973,251
Ensembl chr12:112,938,051...112,976,460
G
OSBPL9
oxysterol binding protein like 9
increases expression
EXP
alpha phellandrene results in increased expression of OSBPL9 mRNA
CTD
PMID:25075043
NCBI chr 1:51,518,272...51,789,219
Ensembl chr 1:51,577,179...51,798,427
G
PABIR2
PABIR family member 2
increases expression
EXP
alpha phellandrene results in increased expression of PABIR2 mRNA
CTD
PMID:25075043
NCBI chr X:134,769,566...134,797,205
Ensembl chr X:134,769,566...134,797,232
G
PARP14
poly(ADP-ribose) polymerase family member 14
increases expression
EXP
alpha phellandrene results in increased expression of PARP14 mRNA
CTD
PMID:25075043
NCBI chr 3:122,680,839...122,730,840
Ensembl chr 3:122,680,839...122,730,840
G
PCYOX1L
prenylcysteine oxidase 1 like
decreases expression
EXP
alpha phellandrene results in decreased expression of PCYOX1L mRNA
CTD
PMID:25075043
NCBI chr 5:149,358,046...149,369,653
Ensembl chr 5:149,358,037...149,369,653
G
PDE3B
phosphodiesterase 3B
increases expression
EXP
alpha phellandrene results in increased expression of PDE3B mRNA
CTD
PMID:25075043
NCBI chr11:14,643,804...14,899,321
Ensembl chr11:14,643,804...14,872,044
G
PHOSPHO1
phosphoethanolamine/phosphocholine phosphatase 1
increases expression
EXP
alpha phellandrene results in increased expression of PHOSPHO1 mRNA
CTD
PMID:25075043
NCBI chr17:49,223,366...49,230,787
Ensembl chr17:49,223,366...49,230,787
G
PIK3CB
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
increases expression
EXP
alpha phellandrene results in increased expression of PIK3CB mRNA
CTD
PMID:25075043
NCBI chr 3:138,652,698...138,834,928
Ensembl chr 3:138,652,336...138,834,928
G
PLD4
phospholipase D family member 4
increases expression
EXP
alpha phellandrene results in increased expression of PLD4 mRNA
CTD
PMID:25075043
NCBI chr14:104,924,879...104,937,785
Ensembl chr14:104,924,713...104,937,761
G
PLXDC1
plexin domain containing 1
increases expression
EXP
alpha phellandrene results in increased expression of PLXDC1 mRNA
CTD
PMID:25075043
NCBI chr17:39,063,313...39,152,967
Ensembl chr17:39,063,313...39,154,394
G
PNRC2
proline rich nuclear receptor coactivator 2
increases expression
EXP
alpha phellandrene results in increased expression of PNRC2 mRNA
CTD
PMID:25075043
NCBI chr 1:23,959,164...23,963,462
Ensembl chr 1:23,956,839...23,963,462
G
POLR1B
RNA polymerase I subunit B
decreases expression
EXP
alpha phellandrene results in decreased expression of POLR1B mRNA
CTD
PMID:25075043
NCBI chr 2:112,542,036...112,579,818
Ensembl chr 2:112,541,915...112,579,818
G
POP1
POP1 homolog, ribonuclease P/MRP subunit
decreases expression
EXP
alpha phellandrene results in decreased expression of POP1 mRNA
CTD
PMID:25075043
NCBI chr 8:98,117,293...98,159,835
Ensembl chr 8:98,117,293...98,159,835
G
PPAN
peter pan homolog
decreases expression
EXP
alpha phellandrene results in decreased expression of PPAN mRNA
CTD
PMID:25075043
NCBI chr19:10,106,223...10,112,012
Ensembl chr19:10,106,362...10,112,012
G
PPAT
phosphoribosyl pyrophosphate amidotransferase
decreases expression
EXP
alpha phellandrene results in decreased expression of PPAT mRNA
CTD
PMID:25075043
NCBI chr 4:56,393,362...56,435,615
Ensembl chr 4:56,393,362...56,435,615
G
PPM1K
protein phosphatase, Mg2+/Mn2+ dependent 1K
increases expression
EXP
alpha phellandrene results in increased expression of PPM1K mRNA
CTD
PMID:25075043
NCBI chr 4:88,257,620...88,284,561
Ensembl chr 4:88,257,620...88,284,769
G
PPP2R5C
protein phosphatase 2 regulatory subunit B'gamma
increases expression
EXP
alpha phellandrene results in increased expression of PPP2R5C mRNA
CTD
PMID:25075043
NCBI chr14:101,760,573...101,927,992
Ensembl chr14:101,761,709...101,927,989
G
PPRC1
PPARG related coactivator 1
decreases expression
EXP
alpha phellandrene results in decreased expression of PPRC1 mRNA
CTD
PMID:25075043
NCBI chr10:102,119,889...102,150,333
Ensembl chr10:102,132,994...102,150,333
G
PRKDC
protein kinase, DNA-activated, catalytic subunit
decreases expression
ISO
alpha phellandrene results in decreased expression of PRKDC protein
CTD
PMID:24861204
NCBI chr 8:47,773,111...47,960,136
Ensembl chr 8:47,773,111...47,960,178
G
PRSS1
serine protease 1
decreases expression
EXP
alpha phellandrene results in decreased expression of TRY10 mRNA
CTD
PMID:25075043
NCBI chr 7:142,749,472...142,753,072
Ensembl chr 7:142,749,468...142,753,072
G
PTBP3
polypyrimidine tract binding protein 3
increases expression
EXP
alpha phellandrene results in increased expression of PTBP3 mRNA
CTD
PMID:25075043
NCBI chr 9:112,217,715...112,379,882
Ensembl chr 9:112,217,716...112,333,664
G
PTPMT1
protein tyrosine phosphatase mitochondrial 1
decreases expression
EXP
alpha phellandrene results in decreased expression of PTPMT1 mRNA
CTD
PMID:25075043
NCBI chr11:47,565,599...47,573,461
Ensembl chr11:47,565,430...47,573,461
G
PTPN7
protein tyrosine phosphatase non-receptor type 7
decreases expression
EXP
alpha phellandrene results in decreased expression of PTPN7 mRNA
CTD
PMID:25075043
NCBI chr 1:202,147,013...202,161,588
Ensembl chr 1:202,147,012...202,161,588
G
PUS7
pseudouridine synthase 7
decreases expression
EXP
alpha phellandrene results in decreased expression of PUS7 mRNA
CTD
PMID:25075043
NCBI chr 7:105,456,501...105,522,271
Ensembl chr 7:105,439,661...105,522,271
G
PUS7L
pseudouridine synthase 7 like
decreases expression
EXP
alpha phellandrene results in decreased expression of PUS7L mRNA
CTD
PMID:25075043
NCBI chr12:43,718,992...43,758,790
Ensembl chr12:43,718,992...43,758,793
G
RAD51C
RAD51 paralog C
increases expression
EXP
alpha phellandrene results in increased expression of RAD51C mRNA
CTD
PMID:25075043
NCBI chr17:58,692,573...58,735,611
Ensembl chr17:58,692,573...58,735,611
G
RAP2B
RAP2B, member of RAS oncogene family
increases expression
EXP
alpha phellandrene results in increased expression of RAP2B mRNA
CTD
PMID:25075043
NCBI chr 3:153,162,226...153,170,627
Ensembl chr 3:153,162,226...153,170,627
G
RBM12B
RNA binding motif protein 12B
decreases expression
EXP
alpha phellandrene results in decreased expression of RBM12B2 mRNA
CTD
PMID:25075043
NCBI chr 8:93,728,155...93,741,009
Ensembl chr 8:93,728,155...93,741,017
G
RBPJ
recombination signal binding protein for immunoglobulin kappa J region
increases expression
EXP
alpha phellandrene results in increased expression of RBPJ mRNA
CTD
PMID:25075043
NCBI chr 4:26,105,449...26,435,131
Ensembl chr 4:26,163,455...26,435,131
G
RCL1
RNA terminal phosphate cyclase like 1
decreases expression
EXP
alpha phellandrene results in decreased expression of RCL1 mRNA
CTD
PMID:25075043
NCBI chr 9:4,792,944...4,861,066
Ensembl chr 9:4,792,944...4,885,917
G
RHOBTB2
Rho related BTB domain containing 2
increases expression
EXP
alpha phellandrene results in increased expression of RHOBTB2 mRNA
CTD
PMID:25075043
NCBI chr 8:22,950,813...23,020,199
Ensembl chr 8:22,987,417...23,020,509
G
RIGI
RNA sensor RIG-I
increases expression
EXP
alpha phellandrene results in increased expression of RIGI mRNA
CTD
PMID:25075043
NCBI chr 9:32,455,302...32,526,196
Ensembl chr 9:32,455,302...32,526,348
G
RNF141
ring finger protein 141
increases expression
EXP
alpha phellandrene results in increased expression of RNF141 mRNA
CTD
PMID:25075043
NCBI chr11:10,511,673...10,541,187
Ensembl chr11:10,511,673...10,541,230
G
RNF19B
ring finger protein 19B
increases expression
EXP
alpha phellandrene results in increased expression of RNF19B mRNA
CTD
PMID:25075043
NCBI chr 1:32,929,036...32,964,809
Ensembl chr 1:32,936,445...32,964,809
G
RP2
RP2 activator of ARL3 GTPase
increases expression
EXP
alpha phellandrene results in increased expression of RP2 mRNA
CTD
PMID:25075043
NCBI chr X:46,837,043...46,882,358
Ensembl chr X:46,837,043...46,882,358
G
RPP14
ribonuclease P/MRP subunit p14
decreases expression
EXP
alpha phellandrene results in decreased expression of RPP14 mRNA
CTD
PMID:25075043
NCBI chr 3:58,306,245...58,320,193
Ensembl chr 3:58,306,245...58,324,695
G
RPP38
ribonuclease P/MRP subunit p38
decreases expression
EXP
alpha phellandrene results in decreased expression of RPP38 mRNA
CTD
PMID:25075043
NCBI chr10:15,097,355...15,104,257
Ensembl chr10:15,097,180...15,139,818
G
RPS12
ribosomal protein S12
decreases expression
EXP
alpha phellandrene results in decreased expression of RPS12 mRNA
CTD
PMID:25075043
NCBI chr 6:132,814,569...132,817,564
Ensembl chr 6:132,814,569...132,817,564
G
RRAS
RAS related
increases expression
EXP
alpha phellandrene results in increased expression of RRAS mRNA
CTD
PMID:25075043
NCBI chr19:49,635,292...49,640,143
Ensembl chr19:49,635,292...49,640,143
G
RRP12
ribosomal RNA processing 12 homolog
decreases expression
EXP
alpha phellandrene results in decreased expression of RRP12 mRNA
CTD
PMID:25075043
NCBI chr10:97,356,357...97,401,370
Ensembl chr10:97,356,357...97,426,076
G
RRP15
ribosomal RNA processing 15 homolog
decreases expression
EXP
alpha phellandrene results in decreased expression of RRP15 mRNA
CTD
PMID:25075043
NCBI chr 1:218,285,293...218,337,983
Ensembl chr 1:218,285,293...218,337,983
G
RSAD2
radical S-adenosyl methionine domain containing 2
increases expression
EXP
alpha phellandrene results in increased expression of RSAD2 mRNA
CTD
PMID:25075043
NCBI chr 2:6,865,885...6,898,239
Ensembl chr 2:6,865,557...6,898,239
G
RTL1
retrotransposon Gag like 1
decreases expression
EXP
alpha phellandrene results in decreased expression of RTL1 mRNA
CTD
PMID:25075043
NCBI chr14:100,879,753...100,903,722
Ensembl chr14:100,879,753...100,903,722
G
RTL8A
retrotransposon Gag like 8A
increases expression
EXP
alpha phellandrene results in increased expression of RTL8A mRNA
CTD
PMID:25075043
NCBI chr X:135,050,932...135,052,135
Ensembl chr X:135,050,932...135,052,196
G
RTP4
receptor transporter protein 4
increases expression
EXP
alpha phellandrene results in increased expression of RTP4 mRNA
CTD
PMID:25075043
NCBI chr 3:187,368,385...187,372,076
Ensembl chr 3:187,368,385...187,372,076
G
RUBCNL
rubicon like autophagy enhancer
increases expression
EXP
alpha phellandrene results in increased expression of RUBCNL mRNA
CTD
PMID:25075043
NCBI chr13:46,334,681...46,390,042
Ensembl chr13:46,334,681...46,438,190
G
SAMHD1
SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1
increases expression
EXP
alpha phellandrene results in increased expression of SAMHD1 mRNA
CTD
PMID:25075043
NCBI chr20:36,889,773...36,951,708
Ensembl chr20:36,890,229...36,951,893
G
SAT1
spermidine/spermine N1-acetyltransferase 1
increases expression
EXP
alpha phellandrene results in increased expression of SAT1 mRNA
CTD
PMID:25075043
NCBI chr X:23,783,173...23,786,210
Ensembl chr X:23,783,173...23,786,210
G
SDAD1
SDA1 domain containing 1
decreases expression
EXP
alpha phellandrene results in decreased expression of SDAD1 mRNA
CTD
PMID:25075043
NCBI chr 4:75,949,915...75,990,945
Ensembl chr 4:75,940,950...75,990,962
G
SEC14L1
SEC14 like lipid binding 1
increases expression
EXP
alpha phellandrene results in increased expression of SEC14L1 mRNA
CTD
PMID:25075043
NCBI chr17:77,088,685...77,217,101
Ensembl chr17:77,088,749...77,217,101
G
SELENBP1
selenium binding protein 1
increases expression
EXP
alpha phellandrene results in increased expression of SELENBP1 mRNA; alpha phellandrene results in increased expression of SELENBP2 mRNA
CTD
PMID:25075043
NCBI chr 1:151,364,304...151,372,705
Ensembl chr 1:151,364,304...151,372,707
G
SEMA3C
semaphorin 3C
decreases expression
EXP
alpha phellandrene results in decreased expression of SEMA3C mRNA
CTD
PMID:25075043
NCBI chr 7:80,742,538...80,922,389
Ensembl chr 7:80,742,538...80,922,359
G
SENP2
SUMO specific peptidase 2
decreases expression
EXP
alpha phellandrene results in decreased expression of SENP2 mRNA
CTD
PMID:25075043
NCBI chr 3:185,586,295...185,633,551
Ensembl chr 3:185,582,496...185,633,551
G
SEPTIN8
septin 8
increases expression
EXP
alpha phellandrene results in increased expression of SEPT8 mRNA
CTD
PMID:25075043
NCBI chr 5:132,750,819...132,780,083
Ensembl chr 5:132,750,819...132,807,241
G
SERTAD3
SERTA domain containing 3
increases expression
EXP
alpha phellandrene results in increased expression of SERTAD3 mRNA
CTD
PMID:25075043
NCBI chr19:40,440,844...40,444,335
Ensembl chr19:40,440,844...40,444,335
G
SET
SET nuclear proto-oncogene
decreases expression
EXP
alpha phellandrene results in decreased expression of SET mRNA
CTD
PMID:25075043
NCBI chr 9:128,683,424...128,696,396
Ensembl chr 9:128,683,424...128,696,400
G
SFN
stratifin
increases expression
ISO
alpha phellandrene results in increased expression of SFN protein
CTD
PMID:24861204
NCBI chr 1:26,863,149...26,864,456
Ensembl chr 1:26,863,149...26,864,456
G
SGF29
SAGA complex associated factor 29
decreases expression
EXP
alpha phellandrene results in decreased expression of SGF29 mRNA
CTD
PMID:25075043
NCBI chr16:28,553,920...28,591,790
Ensembl chr16:28,553,915...28,591,790
G
SGO2
shugoshin 2
increases expression
EXP
alpha phellandrene results in increased expression of SGO2A mRNA
CTD
PMID:25075043
NCBI chr 2:200,526,142...200,584,096
Ensembl chr 2:200,510,008...200,584,096
G
SIGMAR1
sigma non-opioid intracellular receptor 1
decreases expression
EXP
alpha phellandrene results in decreased expression of SIGMAR1 mRNA
CTD
PMID:25075043
NCBI chr 9:34,634,722...34,637,787
Ensembl chr 9:34,634,722...34,637,844
G
SLC1A5
solute carrier family 1 member 5
decreases expression
EXP
alpha phellandrene results in decreased expression of SLC1A5 mRNA
CTD
PMID:25075043
NCBI chr19:46,774,883...46,788,594
Ensembl chr19:46,774,883...46,788,594
G
SLC35B1
solute carrier family 35 member B1
decreases expression
EXP
alpha phellandrene results in decreased expression of SLC35B1 mRNA
CTD
PMID:25075043
NCBI chr17:49,700,943...49,708,197
Ensembl chr17:49,700,934...49,709,014
G
SLC35D1
solute carrier family 35 member D1
decreases expression
EXP
alpha phellandrene results in decreased expression of SLC35D1 mRNA
CTD
PMID:25075043
NCBI chr 1:66,972,976...67,054,148
Ensembl chr 1:66,999,350...67,054,148
G
SLC44A1
solute carrier family 44 member 1
increases expression
EXP
alpha phellandrene results in increased expression of SLC44A1 mRNA
CTD
PMID:25075043
NCBI chr 9:105,244,651...105,438,504
Ensembl chr 9:105,244,622...105,439,171
G
SLC44A3
solute carrier family 44 member 3
increases expression
EXP
alpha phellandrene results in increased expression of SLC44A3 mRNA
CTD
PMID:25075043
NCBI chr 1:94,820,357...94,895,247
Ensembl chr 1:94,820,342...94,895,246
G
SLC7A1
solute carrier family 7 member 1
decreases expression
EXP
alpha phellandrene results in decreased expression of SLC7A1 mRNA
CTD
PMID:25075043
NCBI chr13:29,509,414...29,595,688
Ensembl chr13:29,509,414...29,595,688
G
SLC7A11
solute carrier family 7 member 11
decreases expression
EXP
alpha phellandrene results in decreased expression of SLC7A11 mRNA
CTD
PMID:25075043
NCBI chr 4:138,164,097...138,312,671
Ensembl chr 4:138,164,097...138,242,349
G
SLC7A6
solute carrier family 7 member 6
decreases expression
EXP
alpha phellandrene results in decreased expression of SLC7A6 mRNA
CTD
PMID:25075043
NCBI chr16:68,264,526...68,301,819
Ensembl chr16:68,264,516...68,301,823
G
SLFN5
schlafen family member 5
increases expression
EXP
alpha phellandrene results in increased expression of SLFN4 mRNA; alpha phellandrene results in increased expression of SLFN5 mRNA
CTD
PMID:25075043
NCBI chr17:35,243,072...35,273,655
Ensembl chr17:35,243,071...35,273,655
G
SMIM14
small integral membrane protein 14
increases expression
EXP
alpha phellandrene results in increased expression of SMIM14 mRNA
CTD
PMID:25075043
NCBI chr 4:39,546,336...39,638,865
Ensembl chr 4:39,546,336...39,638,902
G
SMOX
spermine oxidase
increases expression
EXP
alpha phellandrene results in increased expression of SMOX mRNA
CTD
PMID:25075043
NCBI chr20:4,148,828...4,187,727
Ensembl chr20:4,120,980...4,187,747
G
SNHG1
small nucleolar RNA host gene 1
decreases expression
EXP
alpha phellandrene results in decreased expression of SNHG1 mRNA
CTD
PMID:25075043
NCBI chr11:62,851,978...62,855,885
Ensembl chr11:62,851,833...62,856,444
G
SNHG20
small nucleolar RNA host gene 20
decreases expression
EXP
alpha phellandrene results in decreased expression of SNHG20 mRNA
CTD
PMID:25075043
NCBI chr17:77,088,643...77,094,986
Ensembl chr17:77,086,716...77,099,902
G
SNHG5
small nucleolar RNA host gene 5
decreases expression
EXP
alpha phellandrene results in decreased expression of SNHG5 mRNA
CTD
PMID:25075043
NCBI chr 6:85,677,007...85,678,733
Ensembl chr 6:85,644,369...85,678,943
G
SNORA20
small nucleolar RNA, H/ACA box 20
decreases expression
EXP
alpha phellandrene results in decreased expression of SNORA20 mRNA
CTD
PMID:25075043
NCBI chr 6:159,780,250...159,780,381
Ensembl chr 6:159,780,250...159,780,381
G
SNORA21
small nucleolar RNA, H/ACA box 21
decreases expression
EXP
alpha phellandrene results in decreased expression of SNORA21 mRNA
CTD
PMID:25075043
NCBI chr17:38,852,863...38,852,995
Ensembl chr17:38,852,863...38,852,994
G
SNORA26
small nucleolar RNA, H/ACA box 26
decreases expression
EXP
alpha phellandrene results in decreased expression of SNORA26 mRNA
CTD
PMID:25075043
NCBI chr 4:52,713,249...52,713,370
Ensembl chr 4:52,713,249...52,713,370
G
SNORA3A
small nucleolar RNA, H/ACA box 3A
decreases expression
EXP
alpha phellandrene results in decreased expression of SNORA3 mRNA
CTD
PMID:25075043
NCBI chr11:8,684,227...8,684,356
Ensembl chr11:8,684,227...8,684,356
G
SNORA44
small nucleolar RNA, H/ACA box 44
decreases expression
EXP
alpha phellandrene results in decreased expression of SNORA44 mRNA
CTD
PMID:25075043
NCBI chr 1:28,580,381...28,580,512
Ensembl chr 1:28,580,381...28,580,512
G
SNORA61
small nucleolar RNA, H/ACA box 61
decreases expression
EXP
alpha phellandrene results in decreased expression of SNORA61 mRNA
CTD
PMID:25075043
NCBI chr 1:28,579,764...28,579,893
Ensembl chr 1:28,579,764...28,579,893
G
SNORA73A
small nucleolar RNA, H/ACA box 73A
decreases expression
EXP
alpha phellandrene results in decreased expression of SNORA73A mRNA
CTD
PMID:25075043
NCBI chr 1:28,507,365...28,507,571
Ensembl chr 1:28,507,366...28,507,571
G
SNORA73B
small nucleolar RNA, H/ACA box 73B
decreases expression
EXP
alpha phellandrene results in decreased expression of SNORA73B mRNA
CTD
PMID:25075043
NCBI chr 1:28,508,558...28,508,762
Ensembl chr 1:28,508,559...28,508,762
G
SNORA75
small nucleolar RNA, H/ACA box 75
decreases expression
EXP
alpha phellandrene results in decreased expression of SNORA75 mRNA
CTD
PMID:25075043
NCBI chr 2:231,455,800...231,455,936
Ensembl chr 2:231,455,800...231,455,936
G
SNORA7A
small nucleolar RNA, H/ACA box 7A
decreases expression
EXP
alpha phellandrene results in decreased expression of SNORA7A mRNA
CTD
PMID:25075043
NCBI chr 3:12,840,312...12,840,450
Ensembl chr 3:12,840,312...12,840,450
G
SNORD22
small nucleolar RNA, C/D box 22
decreases expression
EXP
alpha phellandrene results in decreased expression of SNORD22 mRNA
CTD
PMID:25075043
NCBI chr11:62,852,910...62,853,035
Ensembl chr11:62,852,910...62,853,035
G
SNORD34
small nucleolar RNA, C/D box 34
decreases expression
EXP
alpha phellandrene results in decreased expression of SNORD34 mRNA
CTD
PMID:25075043
NCBI chr19:49,490,907...49,490,972
Ensembl chr19:49,490,904...49,490,974
G
SNORD47
small nucleolar RNA, C/D box 47
decreases expression
EXP
alpha phellandrene results in decreased expression of SNORD47 mRNA
CTD
PMID:25075043
NCBI chr 1:173,864,369...173,864,445
G
SNORD52
small nucleolar RNA, C/D box 52
decreases expression
EXP
alpha phellandrene results in decreased expression of SNORD52 mRNA
CTD
PMID:25075043
NCBI chr 6:31,837,076...31,837,139
Ensembl chr 6:31,837,076...31,837,142
G
SNORD68
small nucleolar RNA, C/D box 68
decreases expression
EXP
alpha phellandrene results in decreased expression of SNORD68 mRNA
CTD
PMID:25075043
NCBI chr16:89,561,430...89,561,501
Ensembl chr16:89,561,434...89,561,517
G
SNORD82
small nucleolar RNA, C/D box 82
decreases expression
EXP
alpha phellandrene results in decreased expression of SNORD82 mRNA
CTD
PMID:25075043
NCBI chr 2:231,460,368...231,460,442
Ensembl chr 2:231,460,371...231,460,440
G
SNORD87
small nucleolar RNA, C/D box 87
decreases expression
EXP
alpha phellandrene results in decreased expression of SNORD87 mRNA
CTD
PMID:25075043
NCBI chr 8:66,922,474...66,922,549
Ensembl chr 8:66,922,467...66,922,555
G
SNORD95
small nucleolar RNA, C/D box 95
decreases expression
EXP
alpha phellandrene results in decreased expression of SNORD95 mRNA
CTD
PMID:25075043
NCBI chr 5:181,243,314...181,243,376
Ensembl chr 5:181,243,312...181,243,379
G
SNORD96A
small nucleolar RNA, C/D box 96A
decreases expression
EXP
alpha phellandrene results in decreased expression of SNORD96A mRNA
CTD
PMID:25075043
NCBI chr 5:181,241,818...181,241,889
Ensembl chr 5:181,241,814...181,241,892
G
SNRPD2
small nuclear ribonucleoprotein D2 polypeptide
decreases expression
EXP
alpha phellandrene results in decreased expression of SNRPD2 mRNA
CTD
PMID:25075043
NCBI chr19:45,687,454...45,692,316
Ensembl chr19:45,687,460...45,692,569
G
SP100
SP100 nuclear antigen
increases expression
EXP
alpha phellandrene results in increased expression of SP100 mRNA
CTD
PMID:25075043
NCBI chr 2:230,416,201...230,545,606
Ensembl chr 2:230,415,942...230,545,606
G
SP140
SP140 nuclear body protein
increases expression
EXP
alpha phellandrene results in increased expression of SP140 mRNA
CTD
PMID:25075043
NCBI chr 2:230,186,151...230,316,571
Ensembl chr 2:230,203,110...230,313,215
G
SPC25
SPC25 component of NDC80 kinetochore complex
increases expression
EXP
alpha phellandrene results in increased expression of SPC25 mRNA
CTD
PMID:25075043
NCBI chr 2:168,861,521...168,890,430
Ensembl chr 2:168,834,132...168,913,371
G
SPRED3
sprouty related EVH1 domain containing 3
increases expression
EXP
alpha phellandrene results in increased expression of SPRED3 mRNA
CTD
PMID:25075043
NCBI chr19:38,388,697...38,399,587
Ensembl chr19:38,388,421...38,399,587
G
SRI
sorcin
increases expression
EXP
alpha phellandrene results in increased expression of SRI mRNA
CTD
PMID:25075043
NCBI chr 7:88,205,115...88,226,976
Ensembl chr 7:88,205,115...88,226,993
G
SRM
spermidine synthase
decreases expression
EXP
alpha phellandrene results in decreased expression of SRM mRNA
CTD
PMID:25075043
NCBI chr 1:11,054,589...11,060,018
Ensembl chr 1:11,054,584...11,060,020
G
SRR
serine racemase
increases expression
EXP
alpha phellandrene results in increased expression of SRR mRNA
CTD
PMID:25075043
NCBI chr17:2,303,378...2,325,264
Ensembl chr17:2,303,383...2,325,260
G
SRSF7
serine and arginine rich splicing factor 7
decreases expression
EXP
alpha phellandrene results in decreased expression of SRSF7 mRNA
CTD
PMID:25075043
NCBI chr 2:38,743,599...38,751,494
Ensembl chr 2:38,743,599...38,751,494
G
SSR4
signal sequence receptor subunit 4
decreases expression
EXP
alpha phellandrene results in decreased expression of SSR4 mRNA
CTD
PMID:25075043
NCBI chr X:153,794,159...153,798,512
Ensembl chr X:153,793,516...153,798,499
G
ST8SIA5
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5
decreases expression
EXP
alpha phellandrene results in decreased expression of ST8SIA5 mRNA
CTD
PMID:25075043
NCBI chr18:46,667,821...46,757,053
Ensembl chr18:46,667,821...46,759,257
G
STARD3NL
STARD3 N-terminal like
increases expression
EXP
alpha phellandrene results in increased expression of STARD3NL mRNA
CTD
PMID:25075043
NCBI chr 7:38,178,245...38,230,669
Ensembl chr 7:38,178,245...38,230,670
G
STARD5
StAR related lipid transfer domain containing 5
increases expression
EXP
alpha phellandrene results in increased expression of STARD5 mRNA
CTD
PMID:25075043
NCBI chr15:81,309,053...81,324,141
Ensembl chr15:81,309,053...81,324,183
G
STAT1
signal transducer and activator of transcription 1
increases expression
EXP
alpha phellandrene results in increased expression of STAT1 mRNA
CTD
PMID:25075043
NCBI chr 2:190,969,149...191,014,171
Ensembl chr 2:190,908,460...191,020,960
G
STAT2
signal transducer and activator of transcription 2
increases expression
EXP
alpha phellandrene results in increased expression of STAT2 mRNA
CTD
PMID:25075043
NCBI chr12:56,341,597...56,360,107
Ensembl chr12:56,341,597...56,360,203
G
SUPV3L1
Suv3 like RNA helicase
decreases expression
EXP
alpha phellandrene results in decreased expression of SUPV3L1 mRNA
CTD
PMID:25075043
NCBI chr10:69,180,234...69,209,093
Ensembl chr10:69,180,234...69,209,099
G
TAF1D
TATA-box binding protein associated factor, RNA polymerase I subunit D
decreases expression
EXP
alpha phellandrene results in decreased expression of TAF1D mRNA
CTD
PMID:25075043
NCBI chr11:93,730,194...93,741,495
Ensembl chr11:93,729,948...93,784,391
G
TBXAS1
thromboxane A synthase 1
decreases expression
EXP
alpha phellandrene results in decreased expression of TBXAS1 mRNA
CTD
PMID:25075043
NCBI chr 7:139,778,242...140,020,293
Ensembl chr 7:139,777,051...140,020,325
G
TCEANC
transcription elongation factor A N-terminal and central domain containing
increases expression
EXP
alpha phellandrene results in increased expression of TCEANC mRNA
CTD
PMID:25075043
NCBI chr X:13,653,141...13,665,409
Ensembl chr X:13,653,112...13,681,964
G
TCP11L2
t-complex 11 like 2
increases expression
EXP
alpha phellandrene results in increased expression of TCP11L2 mRNA
CTD
PMID:25075043
NCBI chr12:106,297,935...106,347,003
Ensembl chr12:106,301,929...106,347,538
G
TCTN3
tectonic family member 3
increases expression
EXP
alpha phellandrene results in increased expression of TCTN3 mRNA
CTD
PMID:25075043
NCBI chr10:95,663,401...95,693,927
Ensembl chr10:95,659,823...95,694,143
G
TDRD7
tudor domain containing 7
increases expression
EXP
alpha phellandrene results in increased expression of TDRD7 mRNA
CTD
PMID:25075043
NCBI chr 9:97,412,096...97,496,125
Ensembl chr 9:97,412,096...97,496,125
G
TEPSIN
TEPSIN adaptor related protein complex 4 accessory protein
decreases expression
EXP
alpha phellandrene results in decreased expression of TEPSIN mRNA
CTD
PMID:25075043
NCBI chr17:81,228,277...81,239,055
Ensembl chr17:81,228,277...81,239,091
G
TESK2
testis associated actin remodelling kinase 2
increases expression
EXP
alpha phellandrene results in increased expression of TESK2 mRNA
CTD
PMID:25075043
NCBI chr 1:45,343,883...45,491,163
Ensembl chr 1:45,343,883...45,491,163
G
TFAP4
transcription factor AP-4
decreases expression
EXP
alpha phellandrene results in decreased expression of TFAP4 mRNA
CTD
PMID:25075043
NCBI chr16:4,257,186...4,273,023
Ensembl chr16:4,257,186...4,273,075
G
THG1L
tRNA-histidine guanylyltransferase 1 like
decreases expression
EXP
alpha phellandrene results in decreased expression of THG1L mRNA
CTD
PMID:25075043
NCBI chr 5:157,731,420...157,741,449
Ensembl chr 5:157,731,420...157,741,449
G
TIMM10
translocase of inner mitochondrial membrane 10
decreases expression
EXP
alpha phellandrene results in decreased expression of TIMM10 mRNA
CTD
PMID:25075043
NCBI chr11:57,528,464...57,530,754
Ensembl chr11:57,528,464...57,530,803
G
TMEM120A
transmembrane protein 120A
decreases expression
EXP
alpha phellandrene results in decreased expression of TMEM120A mRNA
CTD
PMID:25075043
NCBI chr 7:75,986,831...75,994,595
Ensembl chr 7:75,986,831...75,994,656
G
TMEM97
transmembrane protein 97
decreases expression
EXP
alpha phellandrene results in decreased expression of TMEM97 mRNA
CTD
PMID:25075043
NCBI chr17:28,319,200...28,328,685
Ensembl chr17:28,319,200...28,328,685
G
TMSB10
thymosin beta 10
increases expression
EXP
alpha phellandrene results in increased expression of TMSB10 mRNA
CTD
PMID:25075043
NCBI chr 2:84,905,656...84,906,671
Ensembl chr 2:84,905,656...84,906,671
G
TMSB4X
thymosin beta 4 X-linked
increases expression
EXP
alpha phellandrene results in increased expression of TMSB4X mRNA
CTD
PMID:25075043
NCBI chr X:12,975,110...12,977,223
Ensembl chr X:12,975,110...12,977,227
G
TP53
tumor protein p53
increases expression decreases expression increases phosphorylation affects localization
ISO EXP
alpha phellandrene results in increased expression of TRP53 protein modified form alpha phellandrene results in decreased expression of TRP53 protein alpha phellandrene results in increased phosphorylation of TRP53 protein alpha phellandrene affects the localization of TP53 protein
CTD
PMID:24861204 PMID:25649747
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,546
G
TPD52
tumor protein D52
increases expression
EXP
alpha phellandrene results in increased expression of TPD52 mRNA
CTD
PMID:25075043
NCBI chr 8:80,031,082...80,171,564
Ensembl chr 8:80,034,745...80,231,232
G
TPM4
tropomyosin 4
increases expression
EXP
alpha phellandrene results in increased expression of TPM4 mRNA
CTD
PMID:25075043
NCBI chr19:16,067,538...16,103,002
Ensembl chr19:16,067,021...16,103,005
G
TRIM21
tripartite motif containing 21
increases expression
EXP
alpha phellandrene results in increased expression of TRIM21 mRNA
CTD
PMID:25075043
NCBI chr11:4,384,897...4,393,702
Ensembl chr11:4,384,897...4,393,702
G
TRIM22
tripartite motif containing 22
increases expression
EXP
alpha phellandrene results in increased expression of TRIM30A mRNA
CTD
PMID:25075043
NCBI chr11:5,689,790...5,710,863
Ensembl chr11:5,689,610...5,737,089
G
TSPOAP1
TSPO associated protein 1
increases expression
EXP
alpha phellandrene results in increased expression of TSPOAP1 mRNA
CTD
PMID:25075043
NCBI chr17:58,301,231...58,328,795
Ensembl chr17:58,301,228...58,328,795
G
TSR1
TSR1 ribosome maturation factor
decreases expression
EXP
alpha phellandrene results in decreased expression of TSR1 mRNA
CTD
PMID:25075043
NCBI chr17:2,322,396...2,336,457
Ensembl chr17:2,322,396...2,336,657
G
TSTD3
thiosulfate sulfurtransferase like domain containing 3
increases expression
EXP
alpha phellandrene results in increased expression of TSTD3 mRNA
CTD
PMID:25075043
NCBI chr 6:99,521,049...99,587,775
Ensembl chr 6:99,520,976...99,589,899
G
TTC27
tetratricopeptide repeat domain 27
decreases expression
EXP
alpha phellandrene results in decreased expression of TTC27 mRNA
CTD
PMID:25075043
NCBI chr 2:32,628,050...32,821,051
Ensembl chr 2:32,628,032...32,821,051
G
UBASH3A
ubiquitin associated and SH3 domain containing A
decreases expression
EXP
alpha phellandrene results in decreased expression of UBASH3A mRNA
CTD
PMID:25075043
NCBI chr21:42,403,902...42,447,684
Ensembl chr21:42,403,447...42,447,684
G
UBE2H
ubiquitin conjugating enzyme E2 H
increases expression
EXP
alpha phellandrene results in increased expression of UBE2H mRNA
CTD
PMID:25075043
NCBI chr 7:129,830,732...129,952,960
Ensembl chr 7:129,830,732...129,952,960
G
URB2
URB2 ribosome biogenesis homolog
decreases expression
EXP
alpha phellandrene results in decreased expression of URB2 mRNA
CTD
PMID:25075043
NCBI chr 1:229,626,247...229,660,200
Ensembl chr 1:229,626,247...229,660,200
G
USP18
ubiquitin specific peptidase 18
increases expression
EXP
alpha phellandrene results in increased expression of USP18 mRNA
CTD
PMID:25075043
NCBI chr22:18,150,170...18,177,397
Ensembl chr22:18,149,843...18,177,397
G
USP22
ubiquitin specific peptidase 22
increases expression
EXP
alpha phellandrene results in increased expression of USP22 mRNA
CTD
PMID:25075043
NCBI chr17:20,999,596...21,043,419
Ensembl chr17:20,999,596...21,043,760
G
USP36
ubiquitin specific peptidase 36
decreases expression
EXP
alpha phellandrene results in decreased expression of USP36 mRNA
CTD
PMID:25075043
NCBI chr17:78,787,381...78,841,439
Ensembl chr17:78,787,381...78,841,441
G
UTP20
UTP20 small subunit processome component
decreases expression
EXP
alpha phellandrene results in decreased expression of UTP20 mRNA
CTD
PMID:25075043
NCBI chr12:101,280,105...101,386,618
Ensembl chr12:101,280,105...101,386,618
G
WDR12
WD repeat domain 12
decreases expression
EXP
alpha phellandrene results in decreased expression of WDR12 mRNA
CTD
PMID:25075043
NCBI chr 2:202,874,261...202,911,673
Ensembl chr 2:202,874,261...203,014,798
G
WDR3
WD repeat domain 3
decreases expression
EXP
alpha phellandrene results in decreased expression of WDR3 mRNA
CTD
PMID:25075043
NCBI chr 1:117,929,739...117,966,543
Ensembl chr 1:117,929,720...117,966,543
G
WDR74
WD repeat domain 74
decreases expression
EXP
alpha phellandrene results in decreased expression of WDR74 mRNA
CTD
PMID:25075043
NCBI chr11:62,832,905...62,841,809
Ensembl chr11:62,832,342...62,841,809
G
WDR75
WD repeat domain 75
decreases expression
EXP
alpha phellandrene results in decreased expression of WDR75 mRNA
CTD
PMID:25075043
NCBI chr 2:189,441,474...189,475,552
Ensembl chr 2:189,441,446...189,475,552
G
WDSUB1
WD repeat, sterile alpha motif and U-box domain containing 1
increases expression
EXP
alpha phellandrene results in increased expression of WDSUB1 mRNA
CTD
PMID:25075043
NCBI chr 2:159,235,798...159,286,703
Ensembl chr 2:159,235,798...159,286,703
G
WIPI1
WD repeat domain, phosphoinositide interacting 1
increases expression
EXP
alpha phellandrene results in increased expression of WIPI1 mRNA
CTD
PMID:25075043
NCBI chr17:68,421,281...68,457,496
Ensembl chr17:68,420,948...68,457,513
G
XAF1
XIAP associated factor 1
increases expression
EXP
alpha phellandrene results in increased expression of XAF1 mRNA
CTD
PMID:25075043
NCBI chr17:6,755,447...6,775,647
Ensembl chr17:6,755,447...6,775,647
G
YARS2
tyrosyl-tRNA synthetase 2
decreases expression
EXP
alpha phellandrene results in decreased expression of YARS2 mRNA
CTD
PMID:25075043
NCBI chr12:32,746,544...32,755,897
Ensembl chr12:32,727,490...32,755,897
G
ZBP1
Z-DNA binding protein 1
increases expression
EXP
alpha phellandrene results in increased expression of ZBP1 mRNA
CTD
PMID:25075043
NCBI chr20:57,603,852...57,620,426
Ensembl chr20:57,603,846...57,620,576
G
ZFAS1
ZNFX1 antisense RNA 1
decreases expression
EXP
alpha phellandrene results in decreased expression of ZFAS1 mRNA
CTD
PMID:25075043
NCBI chr20:49,278,178...49,289,260
Ensembl chr20:49,277,054...49,299,600
G
ZNF260
zinc finger protein 260
increases expression
EXP
alpha phellandrene results in increased expression of ZFP260 mRNA
CTD
PMID:25075043
NCBI chr19:36,510,687...36,528,271
Ensembl chr19:36,510,687...36,528,271
G
ZNF346
zinc finger protein 346
decreases expression
EXP
alpha phellandrene results in decreased expression of ZFP346 mRNA
CTD
PMID:25075043
NCBI chr 5:177,022,696...177,081,189
Ensembl chr 5:177,022,696...177,081,189
G
ZNF717
zinc finger protein 717
increases expression
EXP
alpha phellandrene results in increased expression of ZFP719 mRNA
CTD
PMID:25075043
NCBI chr 3:75,694,701...75,785,549
Ensembl chr 3:75,678,660...75,785,583
G
ZNF778
zinc finger protein 778
decreases expression
EXP
alpha phellandrene results in decreased expression of ZFP882 mRNA
CTD
PMID:25075043
NCBI chr16:89,217,703...89,237,141
Ensembl chr16:89,217,703...89,237,141
G
AATF
apoptosis antagonizing transcription factor
decreases expression
EXP
alpha phellandrene results in decreased expression of AATF mRNA
CTD
PMID:25075043
NCBI chr17:36,948,954...37,056,871
Ensembl chr17:36,948,925...37,056,871
G
ACP1
acid phosphatase 1
decreases expression
EXP
alpha phellandrene results in decreased expression of ACP1 mRNA
CTD
PMID:25075043
NCBI chr 2:264,947...278,283
Ensembl chr 2:264,140...278,283
G
ACSS2
acyl-CoA synthetase short chain family member 2
increases expression
EXP
alpha phellandrene results in increased expression of ACSS2 mRNA
CTD
PMID:25075043
NCBI chr20:34,874,989...34,927,959
Ensembl chr20:34,872,146...34,927,962
G
ADAM18
ADAM metallopeptidase domain 18
decreases expression
EXP
alpha phellandrene results in decreased expression of ADAM18 mRNA
CTD
PMID:25075043
NCBI chr 8:39,584,568...39,730,065
Ensembl chr 8:39,584,489...39,730,065
G
ADAM3A
ADAM metallopeptidase domain 3A (pseudogene)
decreases expression
EXP
alpha phellandrene results in decreased expression of ADAM3 mRNA
CTD
PMID:25075043
NCBI chr 8:39,451,045...39,522,989
Ensembl chr 8:39,451,045...39,522,852 Ensembl chr 8:39,451,045...39,522,852
G
AFG2A
AFG2 AAA ATPase homolog A
decreases expression
EXP
alpha phellandrene results in decreased expression of AFG2A mRNA
CTD
PMID:25075043
NCBI chr 4:122,923,078...123,319,433
Ensembl chr 4:122,923,070...123,319,433
G
AKT1
AKT serine/threonine kinase 1
decreases expression
EXP
alpha phellandrene results in decreased expression of AKT1 protein
CTD
PMID:25649747
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759
G
ALDH1L2
aldehyde dehydrogenase 1 family member L2
increases expression
EXP
alpha phellandrene results in increased expression of ALDH1L2 mRNA
CTD
PMID:25075043
NCBI chr12:105,019,790...105,084,458
Ensembl chr12:105,019,784...105,107,643
G
ALDOC
aldolase, fructose-bisphosphate C
increases expression
EXP
alpha phellandrene results in increased expression of ALDOC mRNA
CTD
PMID:25075043
NCBI chr17:28,573,120...28,576,895
Ensembl chr17:28,573,115...28,576,948
G
ANKRD49
ankyrin repeat domain 49
decreases expression
EXP
alpha phellandrene results in decreased expression of ANKRD49 mRNA
CTD
PMID:25075043
NCBI chr11:94,493,984...94,499,578
Ensembl chr11:94,493,979...94,499,578
G
ANXA1
annexin A1
increases expression
EXP
alpha phellandrene results in increased expression of ANXA1 mRNA
CTD
PMID:25075043
NCBI chr 9:73,151,865...73,170,393
Ensembl chr 9:73,151,865...73,170,629
G
ANXA9
annexin A9
decreases expression
EXP
alpha phellandrene results in decreased expression of ANXA9 mRNA
CTD
PMID:25075043
NCBI chr 1:150,977,306...150,995,634
Ensembl chr 1:150,982,249...150,995,634
G
AP3M2
adaptor related protein complex 3 subunit mu 2
increases expression
EXP
alpha phellandrene results in increased expression of AP3M2 mRNA
CTD
PMID:25075043
NCBI chr 8:42,153,063...42,171,183
Ensembl chr 8:42,152,946...42,171,673
G
ARG2
arginase 2
increases expression
EXP
alpha phellandrene results in increased expression of ARG2 mRNA
CTD
PMID:25075043
NCBI chr14:67,619,920...67,651,708
Ensembl chr14:67,619,920...67,651,708
G
ARHGEF12
Rho guanine nucleotide exchange factor 12
increases expression
EXP
alpha phellandrene results in increased expression of ARHGEF12 mRNA
CTD
PMID:25075043
NCBI chr11:120,336,413...120,489,937
Ensembl chr11:120,336,413...120,489,937
G
ARSK
arylsulfatase family member K
decreases expression
EXP
alpha phellandrene results in decreased expression of ARSK mRNA
CTD
PMID:25075043
NCBI chr 5:95,555,101...95,605,102
Ensembl chr 5:95,555,101...95,605,102
G
ASPA
aspartoacylase
increases expression
EXP
alpha phellandrene results in increased expression of ASPA mRNA
CTD
PMID:25075043
NCBI chr17:3,474,110...3,503,405
Ensembl chr17:3,472,374...3,503,405
G
ATF3
activating transcription factor 3
increases expression
EXP
alpha phellandrene results in increased expression of ATF3 mRNA
CTD
PMID:25075043
NCBI chr 1:212,565,407...212,620,777
Ensembl chr 1:212,565,334...212,620,777
G
BCL2
BCL2 apoptosis regulator
increases phosphorylation
EXP
alpha phellandrene results in increased phosphorylation of BCL2 protein
CTD
PMID:25649747
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
G
BECN1
beclin 1
increases phosphorylation
EXP
alpha phellandrene results in increased phosphorylation of BECN1 protein
CTD
PMID:25649747
NCBI chr17:42,810,132...42,824,282
Ensembl chr17:42,810,134...42,833,350
G
BMF
Bcl2 modifying factor
increases expression
EXP
alpha phellandrene results in increased expression of BMF mRNA
CTD
PMID:25075043
NCBI chr15:40,087,890...40,108,879
Ensembl chr15:40,087,890...40,108,892
G
BNIP3
BCL2 interacting protein 3
increases expression
EXP
alpha phellandrene results in increased expression of BNIP3 mRNA
CTD
PMID:25075043
NCBI chr10:131,967,684...131,981,923
Ensembl chr10:131,967,684...131,981,967
G
BOD1
biorientation of chromosomes in cell division 1
increases expression
EXP
alpha phellandrene results in increased expression of BOD1 mRNA
CTD
PMID:25075043
NCBI chr 5:173,607,145...173,616,650
Ensembl chr 5:173,607,145...173,616,659
G
BRCA1
BRCA1 DNA repair associated
decreases expression
ISO
alpha phellandrene results in decreased expression of BRCA1 protein
CTD
PMID:24861204
NCBI chr17:43,044,295...43,170,327
Ensembl chr17:43,044,295...43,170,245
G
BTG2
BTG anti-proliferation factor 2
increases expression
EXP
alpha phellandrene results in increased expression of BTG2 mRNA
CTD
PMID:25075043
NCBI chr 1:203,305,519...203,309,602
Ensembl chr 1:203,305,491...203,309,602
G
C9orf72
C9orf72-SMCR8 complex subunit
increases expression
EXP
alpha phellandrene results in increased expression of C9ORF72 mRNA
CTD
PMID:25075043
NCBI chr 9:27,546,546...27,573,866
Ensembl chr 9:27,535,640...27,573,866
G
CALM2
calmodulin 2
increases expression
EXP
alpha phellandrene results in increased expression of CALM2 mRNA
CTD
PMID:25075043
NCBI chr 2:47,160,082...47,176,936
Ensembl chr 2:47,160,084...47,176,921
G
CAPNS1
calpain small subunit 1
increases expression
EXP
alpha phellandrene results in increased expression of CAPNS1 mRNA
CTD
PMID:25075043
NCBI chr19:36,140,066...36,150,353
Ensembl chr19:36,139,953...36,150,353
G
CAPRIN2
caprin family member 2
increases expression
EXP
alpha phellandrene results in increased expression of CAPRIN2 mRNA
CTD
PMID:25075043
NCBI chr12:30,709,553...30,754,951
Ensembl chr12:30,709,552...30,823,302
G
CARD6
caspase recruitment domain family member 6
increases expression
EXP
alpha phellandrene results in increased expression of CARD6 mRNA
CTD
PMID:25075043
NCBI chr 5:40,841,367...40,855,354
Ensembl chr 5:40,841,308...40,860,175
G
CARHSP1
calcium regulated heat stable protein 1
increases expression
EXP
alpha phellandrene results in increased expression of CARHSP1 mRNA
CTD
PMID:25075043
NCBI chr16:8,852,942...8,869,006
Ensembl chr16:8,852,942...8,869,012
G
CCL5
C-C motif chemokine ligand 5
increases expression
EXP
alpha phellandrene results in increased expression of CCL5 mRNA
CTD
PMID:25075043
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
G
CCNG2
cyclin G2
increases expression
EXP
alpha phellandrene results in increased expression of CCNG2 mRNA
CTD
PMID:25075043
NCBI chr 4:77,157,207...77,170,060
Ensembl chr 4:77,157,207...77,433,388
G
CCRL2
C-C motif chemokine receptor like 2
increases expression
EXP
alpha phellandrene results in increased expression of CCRL2 mRNA
CTD
PMID:25075043
NCBI chr 3:46,407,259...46,409,523
Ensembl chr 3:46,407,166...46,412,997
G
CD59
CD59 molecule (CD59 blood group)
decreases expression
EXP
alpha phellandrene results in decreased expression of CD59A mRNA
CTD
PMID:25075043
NCBI chr11:33,703,010...33,736,479
Ensembl chr11:33,703,010...33,736,479
G
CDCP2
CUB domain containing protein 2
increases expression
EXP
alpha phellandrene results in increased expression of CDCP2 mRNA
CTD
PMID:25075043
NCBI chr 1:54,132,687...54,153,000
Ensembl chr 1:54,132,687...54,153,770
G
CDKN1A
cyclin dependent kinase inhibitor 1A
increases expression
EXP
alpha phellandrene results in increased expression of CDKN1A mRNA
CTD
PMID:25075043
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,397
G
CDKN2D
cyclin dependent kinase inhibitor 2D
increases expression
EXP
alpha phellandrene results in increased expression of CDKN2D mRNA
CTD
PMID:25075043
NCBI chr19:10,566,460...10,568,979
Ensembl chr19:10,566,460...10,569,059
G
CFLAR
CASP8 and FADD like apoptosis regulator
increases expression
EXP
alpha phellandrene results in increased expression of CFLAR mRNA
CTD
PMID:25075043
NCBI chr 2:201,116,164...201,176,687
Ensembl chr 2:201,116,154...201,176,687
G
CLEC12A
C-type lectin domain family 12 member A
decreases expression
EXP
alpha phellandrene results in decreased expression of CLEC12A mRNA
CTD
PMID:25075043
NCBI chr12:9,951,268...10,006,150
Ensembl chr12:9,951,316...9,995,694
G
CLEC4D
C-type lectin domain family 4 member D
decreases expression
EXP
alpha phellandrene results in decreased expression of CLEC4D mRNA
CTD
PMID:25075043
NCBI chr12:8,513,503...8,531,696
Ensembl chr12:8,509,475...8,522,366
G
CLEC6A
C-type lectin domain containing 6A
decreases expression
EXP
alpha phellandrene results in decreased expression of CLEC4N mRNA
CTD
PMID:25075043
NCBI chr12:8,455,962...8,478,330
Ensembl chr12:8,455,962...8,478,330
G
CLUH
clustered mitochondria homolog
decreases expression
EXP
alpha phellandrene results in decreased expression of CLUH mRNA
CTD
PMID:25075043
NCBI chr17:2,689,387...2,712,020
Ensembl chr17:2,689,386...2,712,663
G
CMPK2
cytidine/uridine monophosphate kinase 2
increases expression
EXP
alpha phellandrene results in increased expression of CMPK2 mRNA
CTD
PMID:25075043
NCBI chr 2:6,840,553...6,866,635
Ensembl chr 2:6,840,570...6,866,635
G
CR1L
complement C3b/C4b receptor 1 like
decreases expression
EXP
alpha phellandrene results in decreased expression of CR1L mRNA
CTD
PMID:25075043
NCBI chr 1:207,645,133...207,723,703
Ensembl chr 1:207,645,113...207,738,416
G
CRISP1
cysteine rich secretory protein 1
decreases expression
EXP
alpha phellandrene results in decreased expression of CRISP1 mRNA
CTD
PMID:25075043
NCBI chr 6:49,834,257...49,877,096
Ensembl chr 6:49,834,257...49,877,096
G
CST7
cystatin F
decreases expression
EXP
alpha phellandrene results in decreased expression of CST7 mRNA
CTD
PMID:25075043
NCBI chr20:24,949,269...24,959,928
Ensembl chr20:24,949,269...24,959,928
G
CSTA
cystatin A
increases expression
EXP
alpha phellandrene results in increased expression of STFA1 mRNA
CTD
PMID:25075043
NCBI chr 3:122,325,248...122,341,969
Ensembl chr 3:122,325,248...122,341,969
G
CTSG
cathepsin G
decreases expression
EXP
alpha phellandrene results in decreased expression of CTSG mRNA
CTD
PMID:25075043
NCBI chr14:24,573,518...24,576,250
Ensembl chr14:24,573,518...24,576,250
G
CXCL10
C-X-C motif chemokine ligand 10
increases expression
EXP
alpha phellandrene results in increased expression of CXCL10 mRNA
CTD
PMID:25075043
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
G
CYB561D2
cytochrome b561 family member D2
decreases expression
EXP
alpha phellandrene results in decreased expression of CYB561D2 mRNA
CTD
PMID:25075043
NCBI chr 3:50,350,862...50,354,069
Ensembl chr 3:50,350,845...50,358,460
G
CYFIP2
cytoplasmic FMR1 interacting protein 2
increases expression
EXP
alpha phellandrene results in increased expression of CYFIP2 mRNA
CTD
PMID:25075043
NCBI chr 5:157,266,123...157,395,594
Ensembl chr 5:157,266,079...157,395,595
G
CYP51A1
cytochrome P450 family 51 subfamily A member 1
decreases expression
EXP
alpha phellandrene results in decreased expression of CYP51 mRNA
CTD
PMID:25075043
NCBI chr 7:92,112,153...92,134,803
Ensembl chr 7:92,084,987...92,134,803
G
DBX1
developing brain homeobox 1
increases expression
EXP
alpha phellandrene results in increased expression of DBX1 mRNA
CTD
PMID:25075043
NCBI chr11:20,156,155...20,160,475
Ensembl chr11:20,156,155...20,160,475
G
DCTD
dCMP deaminase
decreases expression
EXP
alpha phellandrene results in decreased expression of DCTD mRNA
CTD
PMID:25075043
NCBI chr 4:182,890,091...182,917,611
Ensembl chr 4:182,890,060...182,917,936
G
DDIT4
DNA damage inducible transcript 4
increases expression
EXP
alpha phellandrene results in increased expression of DDIT4 mRNA
CTD
PMID:25075043
NCBI chr10:72,273,924...72,276,036
Ensembl chr10:72,273,919...72,276,036
G
DDX31
DEAD-box helicase 31
decreases expression
EXP
alpha phellandrene results in decreased expression of DDX31 mRNA
CTD
PMID:25075043
NCBI chr 9:132,592,997...132,669,983
Ensembl chr 9:132,592,997...132,670,401
G
DDX60
DExD/H-box helicase 60
increases expression
EXP
alpha phellandrene results in increased expression of DDX60 mRNA
CTD
PMID:25075043
NCBI chr 4:168,216,294...168,325,979
Ensembl chr 4:168,216,291...168,318,883
G
DFFB
DNA fragmentation factor subunit beta
increases expression
EXP
alpha phellandrene results in increased expression of DFFB mRNA
CTD
PMID:25075043
NCBI chr 1:3,857,476...3,885,429
Ensembl chr 1:3,857,267...3,885,429
G
DGKA
diacylglycerol kinase alpha
increases expression
EXP
alpha phellandrene results in increased expression of DGKA mRNA
CTD
PMID:25075043
NCBI chr12:55,927,316...55,954,023
Ensembl chr12:55,927,319...55,954,027
G
DHRS1
dehydrogenase/reductase 1
increases expression
EXP
alpha phellandrene results in increased expression of DHRS1 mRNA
CTD
PMID:25075043
NCBI chr14:24,290,598...24,299,780
Ensembl chr14:24,290,598...24,299,780
G
DHX33
DEAH-box helicase 33
decreases expression
EXP
alpha phellandrene results in decreased expression of DHX33 mRNA
CTD
PMID:25075043
NCBI chr17:5,440,917...5,468,982
Ensembl chr17:5,440,917...5,468,982
G
DHX58
DExH-box helicase 58
increases expression
EXP
alpha phellandrene results in increased expression of DHX58 mRNA
CTD
PMID:25075043
NCBI chr17:42,101,411...42,112,714
Ensembl chr17:42,101,404...42,112,714
G
DKC1
dyskerin pseudouridine synthase 1
decreases expression
EXP
alpha phellandrene results in decreased expression of DKC1 mRNA
CTD
PMID:25075043
NCBI chr X:154,762,864...154,777,689
Ensembl chr X:154,762,742...154,777,689
G
DUSP1
dual specificity phosphatase 1
increases expression
EXP
alpha phellandrene results in increased expression of DUSP1 mRNA
CTD
PMID:25075043
NCBI chr 5:172,768,096...172,771,195
Ensembl chr 5:172,768,096...172,771,195
G
DUSP6
dual specificity phosphatase 6
increases expression
EXP
alpha phellandrene results in increased expression of DUSP6 mRNA
CTD
PMID:25075043
NCBI chr12:89,347,235...89,352,501
Ensembl chr12:89,347,235...89,352,501
G
DYNLT3
dynein light chain Tctex-type 3
increases expression
EXP
alpha phellandrene results in increased expression of DYNLT3 mRNA
CTD
PMID:25075043
NCBI chr X:37,838,836...37,847,571
Ensembl chr X:37,836,757...37,847,571
G
EGLN3
egl-9 family hypoxia inducible factor 3
increases expression
EXP
alpha phellandrene results in increased expression of EGLN3 mRNA
CTD
PMID:25075043
NCBI chr14:33,924,227...33,951,074
Ensembl chr14:33,924,227...34,462,774
G
EGR1
early growth response 1
increases expression
EXP
alpha phellandrene results in increased expression of EGR1 mRNA
CTD
PMID:25075043
NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
G
EIF5
eukaryotic translation initiation factor 5
decreases expression
EXP
alpha phellandrene results in decreased expression of EIF5 mRNA
CTD
PMID:25075043
NCBI chr14:103,334,237...103,345,025
Ensembl chr14:103,333,544...103,345,025
G
ELAC2
elaC ribonuclease Z 2
decreases expression
EXP
alpha phellandrene results in decreased expression of ELAC2 mRNA
CTD
PMID:25075043
NCBI chr17:12,991,612...13,018,027
Ensembl chr17:12,991,612...13,018,065
G
ELOVL1
ELOVL fatty acid elongase 1
decreases expression
EXP
alpha phellandrene results in decreased expression of ELOVL1 mRNA
CTD
PMID:25075043
NCBI chr 1:43,363,401...43,368,011
Ensembl chr 1:43,363,398...43,368,074
G
ELOVL7
ELOVL fatty acid elongase 7
increases expression
EXP
alpha phellandrene results in increased expression of ELOVL7 mRNA
CTD
PMID:25075043
NCBI chr 5:60,751,791...60,844,269
Ensembl chr 5:60,751,791...60,844,274
G
ENO2
enolase 2
increases expression
EXP
alpha phellandrene results in increased expression of ENO2 mRNA
CTD
PMID:25075043
NCBI chr12:6,914,580...6,923,697
Ensembl chr12:6,913,745...6,923,698
G
FBXO44
F-box protein 44
increases expression
EXP
alpha phellandrene results in increased expression of FBXO44 mRNA
CTD
PMID:25075043
NCBI chr 1:11,654,407...11,663,327
Ensembl chr 1:11,654,375...11,663,327
G
FGGY
FGGY carbohydrate kinase domain containing
increases expression
EXP
alpha phellandrene results in increased expression of FGGY mRNA
CTD
PMID:25075043
NCBI chr 1:59,296,378...59,762,730
Ensembl chr 1:59,296,638...59,810,647
G
FLVCR1
FLVCR choline and heme transporter 1
decreases expression
EXP
alpha phellandrene results in decreased expression of FLVCR1 mRNA
CTD
PMID:25075043
NCBI chr 1:212,858,275...212,899,363
Ensembl chr 1:212,858,275...212,899,363
G
FOS
Fos proto-oncogene, AP-1 transcription factor subunit
increases expression
EXP
alpha phellandrene results in increased expression of FOS mRNA
CTD
PMID:25075043
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,283,190
G
FOXO1
forkhead box O1
increases expression
EXP
alpha phellandrene results in increased expression of FOXO1 mRNA
CTD
PMID:25075043
NCBI chr13:40,555,667...40,666,641
Ensembl chr13:40,555,667...40,666,641
G
FPR1
formyl peptide receptor 1
decreases expression
EXP
alpha phellandrene results in decreased expression of FPR1 mRNA
CTD
PMID:25075043
NCBI chr19:51,745,172...51,751,878
Ensembl chr19:51,745,172...51,804,115
G
FTH1
ferritin heavy chain 1
increases expression
EXP
alpha phellandrene results in increased expression of FTH1 mRNA
CTD
PMID:25075043
NCBI chr11:61,964,285...61,967,634
Ensembl chr11:61,959,718...61,967,634
G
FTL
ferritin light chain
increases expression
EXP
alpha phellandrene results in increased expression of FTL1 mRNA; alpha phellandrene results in increased expression of FTL2-PS mRNA
CTD
PMID:25075043
NCBI chr19:48,965,309...48,966,879
Ensembl chr19:48,965,309...48,967,896
G
FTSJ3
FtsJ RNA 2'-O-methyltransferase 3
decreases expression
EXP
alpha phellandrene results in decreased expression of FTSJ3 mRNA
CTD
PMID:25075043
NCBI chr17:63,819,433...63,827,663
Ensembl chr17:63,819,433...63,830,012
G
FXN
frataxin
decreases expression
EXP
alpha phellandrene results in decreased expression of FXN mRNA
CTD
PMID:25075043
NCBI chr 9:69,035,752...69,079,076
Ensembl chr 9:69,035,751...69,079,076
G
GABARAP
GABA type A receptor-associated protein
increases expression
EXP
alpha phellandrene results in increased expression of GABARAP mRNA
CTD
PMID:25075043
NCBI chr17:7,240,008...7,242,449
Ensembl chr17:7,240,008...7,242,449
G
GADD45A
growth arrest and DNA damage inducible alpha
increases expression
EXP
alpha phellandrene results in increased expression of GADD45A mRNA
CTD
PMID:25075043
NCBI chr 1:67,685,201...67,688,334
Ensembl chr 1:67,685,201...67,688,334
G
GAS5
growth arrest specific 5
decreases expression
EXP
alpha phellandrene results in decreased expression of GAS5 mRNA
CTD
PMID:25075043
NCBI chr 1:173,863,901...173,869,045
Ensembl chr 1:173,851,424...173,868,940
G
GBP6
guanylate binding protein family member 6
increases expression
EXP
alpha phellandrene results in increased expression of GBP6 mRNA
CTD
PMID:25075043
NCBI chr 1:89,364,059...89,388,160
Ensembl chr 1:89,364,059...89,388,160
G
GNAS
GNAS complex locus
increases expression
EXP
alpha phellandrene results in increased expression of GNAS mRNA
CTD
PMID:25075043
NCBI chr20:58,839,748...58,911,192
Ensembl chr20:58,839,718...58,911,192
G
GNL3
G protein nucleolar 3
decreases expression
EXP
alpha phellandrene results in decreased expression of GNL3 mRNA
CTD
PMID:25075043
NCBI chr 3:52,685,920...52,694,497
Ensembl chr 3:52,681,156...52,694,497
G
GPR84
G protein-coupled receptor 84
decreases expression
EXP
alpha phellandrene results in decreased expression of GPR84 mRNA
CTD
PMID:25075043
NCBI chr12:54,350,698...54,364,486
Ensembl chr12:54,362,445...54,364,487
G
GREB1L
GREB1 like retinoic acid receptor coactivator
increases expression
EXP
alpha phellandrene results in increased expression of GREB1L mRNA
CTD
PMID:25075043
NCBI chr18:21,242,232...21,526,112
Ensembl chr18:21,242,232...21,526,112
G
GRINA
glutamate ionotropic receptor NMDA type subunit associated protein 1
increases expression
EXP
alpha phellandrene results in increased expression of GRINA mRNA
CTD
PMID:25075043
NCBI chr 8:143,990,056...143,993,415
Ensembl chr 8:143,990,056...143,993,415
G
GTDC1
glycosyltransferase like domain containing 1
increases expression
EXP
alpha phellandrene results in increased expression of GTDC1 mRNA
CTD
PMID:25075043
NCBI chr 2:143,938,068...144,333,069
Ensembl chr 2:143,938,068...144,332,568
G
GYS1
glycogen synthase 1
increases expression
EXP
alpha phellandrene results in increased expression of GYS1 mRNA
CTD
PMID:25075043
NCBI chr19:48,968,130...48,993,309
Ensembl chr19:48,968,130...48,993,310
G
GZMH
granzyme H
decreases expression
EXP
alpha phellandrene results in decreased expression of GZME mRNA
CTD
PMID:25075043
NCBI chr14:24,606,480...24,609,685
Ensembl chr14:24,606,480...24,609,699
G
H1-0
H1.0 linker histone
increases expression
EXP
alpha phellandrene results in increased expression of H1F0 mRNA
CTD
PMID:25075043
NCBI chr22:37,805,229...37,807,432
Ensembl chr22:37,805,229...37,807,432
G
H1-2
H1.2 linker histone, cluster member
increases expression
EXP
alpha phellandrene results in increased expression of H1F2 mRNA
CTD
PMID:25075043
NCBI chr 6:26,055,740...26,056,470
Ensembl chr 6:26,054,760...26,056,470
G
H2BC14
H2B clustered histone 14
increases expression
EXP
alpha phellandrene results in increased expression of H2BC14 mRNA
CTD
PMID:25075043
NCBI chr 6:27,815,022...27,815,489
Ensembl chr 6:27,815,022...27,815,489
G
H2BC18
H2B clustered histone 18
increases expression
EXP
alpha phellandrene results in increased expression of H2BC18 mRNA
CTD
PMID:25075043
NCBI chr 1:149,782,689...149,812,370
Ensembl chr 1:149,782,689...149,812,373
G
H2BC4
H2B clustered histone 4
increases expression
EXP
alpha phellandrene results in increased expression of H2BC4 mRNA
CTD
PMID:25075043
NCBI chr 6:26,113,170...26,123,926
Ensembl chr 6:26,086,317...26,123,926
G
H3C4
H3 clustered histone 4
increases expression
EXP
alpha phellandrene results in increased expression of H3C4 mRNA
CTD
PMID:25075043
NCBI chr 6:26,196,784...26,199,293
Ensembl chr 6:26,195,164...26,197,286
G
H4C4
H4 clustered histone 4
increases expression
EXP
alpha phellandrene results in increased expression of H4C4 mRNA
CTD
PMID:25075043
NCBI chr 6:26,188,710...26,189,112
Ensembl chr 6:26,188,710...26,189,112
G
HCAR2
hydroxycarboxylic acid receptor 2
increases expression
EXP
alpha phellandrene results in increased expression of HCAR2 mRNA
CTD
PMID:25075043
NCBI chr12:122,701,293...122,703,357
Ensembl chr12:122,701,293...122,703,357
G
HEATR1
HEAT repeat containing 1
decreases expression
EXP
alpha phellandrene results in decreased expression of HEATR1 mRNA
CTD
PMID:25075043
NCBI chr 1:236,549,005...236,604,516
Ensembl chr 1:236,549,005...236,604,516
G
HELZ2
helicase with zinc finger 2
increases expression
EXP
alpha phellandrene results in increased expression of HELZ2 mRNA
CTD
PMID:25075043
NCBI chr20:63,558,086...63,574,239
Ensembl chr20:63,558,086...63,574,239
G
HGH1
HGH1 homolog
decreases expression
EXP
alpha phellandrene results in decreased expression of BRP16 mRNA
CTD
PMID:25075043
NCBI chr 8:144,137,774...144,140,851
Ensembl chr 8:144,137,774...144,140,851
G
HILPDA
hypoxia inducible lipid droplet associated
increases expression
EXP
alpha phellandrene results in increased expression of HILPDA mRNA
CTD
PMID:25075043
NCBI chr 7:128,455,878...128,458,418
Ensembl chr 7:128,455,849...128,458,418
G
HIVEP3
HIVEP zinc finger 3
increases expression
EXP
alpha phellandrene results in increased expression of HIVEP3 mRNA
CTD
PMID:25075043
NCBI chr 1:41,506,365...42,035,934
Ensembl chr 1:41,506,365...42,035,925
G
HSPA2
heat shock protein family A (Hsp70) member 2
increases expression
EXP
alpha phellandrene results in increased expression of HSPA2 mRNA
CTD
PMID:25075043
NCBI chr14:64,535,905...64,543,237
Ensembl chr14:64,535,905...64,546,173
G
HSPA5
heat shock protein family A (Hsp70) member 5
decreases expression
EXP
alpha phellandrene results in decreased expression of HSPA5 mRNA
CTD
PMID:25075043
NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382
G
HSPA8
heat shock protein family A (Hsp70) member 8
decreases expression
EXP
alpha phellandrene results in decreased expression of HSPA8 mRNA
CTD
PMID:25075043
NCBI chr11:123,057,489...123,062,462
Ensembl chr11:123,057,489...123,063,230
G
ID2
inhibitor of DNA binding 2
increases expression
EXP
alpha phellandrene results in increased expression of ID2 mRNA
CTD
PMID:25075043
NCBI chr 2:8,682,056...8,684,461
Ensembl chr 2:8,678,845...8,684,461
G
IDI1
isopentenyl-diphosphate delta isomerase 1
decreases expression
EXP
alpha phellandrene results in decreased expression of IDI1 mRNA
CTD
PMID:25075043
NCBI chr10:1,039,152...1,056,704
Ensembl chr10:1,039,152...1,049,119
G
IFIH1
interferon induced with helicase C domain 1
increases expression
EXP
alpha phellandrene results in increased expression of IFIH1 mRNA
CTD
PMID:25075043
NCBI chr 2:162,267,074...162,318,684
Ensembl chr 2:162,267,074...162,318,684
G
IFIT1
interferon induced protein with tetratricopeptide repeats 1
increases expression
EXP
alpha phellandrene results in increased expression of IFIT1 mRNA
CTD
PMID:25075043
NCBI chr10:89,392,623...89,406,487
Ensembl chr10:89,392,546...89,406,487
G
IFNL3
interferon lambda 3
increases expression
EXP
alpha phellandrene results in increased expression of IFNL3 mRNA
CTD
PMID:25075043
NCBI chr19:39,243,455...39,245,250
Ensembl chr19:39,243,455...39,245,250
G
IL2RA
interleukin 2 receptor subunit alpha
decreases expression
EXP
alpha phellandrene results in decreased expression of IL2RA mRNA
CTD
PMID:25075043
NCBI chr10:6,010,689...6,062,367
Ensembl chr10:6,010,689...6,062,370
G
IL36G
interleukin 36 gamma
decreases expression
EXP
alpha phellandrene results in decreased expression of IL36G mRNA
CTD
PMID:25075043
NCBI chr 2:112,978,006...112,985,658
Ensembl chr 2:112,973,203...112,985,658
G
IRF5
interferon regulatory factor 5
increases expression
EXP
alpha phellandrene results in increased expression of IRF5 mRNA
CTD
PMID:25075043
NCBI chr 7:128,937,032...128,950,038
Ensembl chr 7:128,937,457...128,950,038
G
IRF7
interferon regulatory factor 7
increases expression
EXP
alpha phellandrene results in increased expression of IRF7 mRNA
CTD
PMID:25075043
NCBI chr11:612,555...615,950
Ensembl chr11:612,553...615,983
G
IRGM
immunity related GTPase M
increases expression
EXP
alpha phellandrene results in increased expression of IRGM2 mRNA
CTD
PMID:25075043
NCBI chr 5:150,846,521...150,902,402
Ensembl chr 5:150,846,521...150,900,736
G
ITGAL
integrin subunit alpha L
increases expression
EXP
alpha phellandrene results in increased expression of ITGAL mRNA
CTD
PMID:25075043
NCBI chr16:30,472,742...30,523,185
Ensembl chr16:30,472,658...30,523,567
G
JAGN1
jagunal homolog 1
decreases expression
EXP
alpha phellandrene results in decreased expression of JAGN1 mRNA
CTD
PMID:25075043
NCBI chr 3:9,890,610...9,894,349
Ensembl chr 3:9,890,574...9,894,349
G
JUN
Jun proto-oncogene, AP-1 transcription factor subunit
increases expression
EXP
alpha phellandrene results in increased expression of JUN mRNA
CTD
PMID:25075043
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
G
KANK2
KN motif and ankyrin repeat domains 2
decreases expression
EXP
alpha phellandrene results in decreased expression of KANK2 mRNA
CTD
PMID:25075043
NCBI chr19:11,164,270...11,197,865
Ensembl chr19:11,164,270...11,197,791
G
KDM7A
lysine demethylase 7A
increases expression
EXP
alpha phellandrene results in increased expression of KDM7A mRNA
CTD
PMID:25075043
NCBI chr 7:140,084,746...140,176,983
Ensembl chr 7:140,084,746...140,176,983
G
KLHL23
kelch like family member 23
increases expression
EXP
alpha phellandrene results in increased expression of KLHL23 mRNA
CTD
PMID:25075043
NCBI chr 2:169,733,832...169,751,878
Ensembl chr 2:169,694,488...169,776,989
G
KLHL24
kelch like family member 24
increases expression
EXP
alpha phellandrene results in increased expression of KLHL24 mRNA
CTD
PMID:25075043
NCBI chr 3:183,635,623...183,684,519
Ensembl chr 3:183,635,610...183,684,519
G
LIMA1
LIM domain and actin binding 1
increases expression
EXP
alpha phellandrene results in increased expression of LIMA1 mRNA
CTD
PMID:25075043
NCBI chr12:50,175,788...50,283,520
Ensembl chr12:50,175,788...50,283,520
G
LLGL2
LLGL scribble cell polarity complex component 2
decreases expression
EXP
alpha phellandrene results in decreased expression of LLGL2 mRNA
CTD
PMID:25075043
NCBI chr17:75,525,002...75,575,209
Ensembl chr17:75,525,080...75,575,209
G
LPP
LIM domain containing preferred translocation partner in lipoma
increases expression
EXP
alpha phellandrene results in increased expression of LPP mRNA
CTD
PMID:25075043
NCBI chr 3:188,153,021...188,890,671
Ensembl chr 3:188,153,284...188,890,671
G
LTN1
listerin E3 ubiquitin protein ligase 1
decreases expression
EXP
alpha phellandrene results in decreased expression of LTN1 mRNA
CTD
PMID:25075043
NCBI chr21:28,928,144...28,992,877
Ensembl chr21:28,928,144...28,992,956
G
LY6H
lymphocyte antigen 6 family member H
decreases expression
EXP
alpha phellandrene results in decreased expression of LY6C1 mRNA; alpha phellandrene results in decreased expression of LY6C2 mRNA
CTD
PMID:25075043
NCBI chr 8:143,157,916...143,160,654
Ensembl chr 8:143,157,914...143,160,711
G
MAP2K6
mitogen-activated protein kinase kinase 6
increases expression
EXP
alpha phellandrene results in increased expression of MAP2K6 mRNA
CTD
PMID:25075043
NCBI chr17:69,414,697...69,553,865
Ensembl chr17:69,414,697...69,553,865
G
MAT2A
methionine adenosyltransferase 2A
decreases expression
EXP
alpha phellandrene results in decreased expression of MAT2A mRNA
CTD
PMID:25075043
NCBI chr 2:85,539,168...85,545,281
Ensembl chr 2:85,539,168...85,545,281
G
MCEMP1
mast cell expressed membrane protein 1
increases expression
EXP
alpha phellandrene results in increased expression of MCEMP1 mRNA
CTD
PMID:25075043
NCBI chr19:7,677,090...7,679,829
Ensembl chr19:7,677,088...7,679,829
G
MDC1
mediator of DNA damage checkpoint 1
increases expression
ISO
alpha phellandrene results in increased expression of MDC1 protein
CTD
PMID:24861204
NCBI chr 6:30,699,807...30,717,281
Ensembl chr 6:30,699,807...30,717,447
G
MDN1
midasin AAA ATPase 1
decreases expression
EXP
alpha phellandrene results in decreased expression of MDN1 mRNA
CTD
PMID:25075043
NCBI chr 6:89,642,498...89,819,794
Ensembl chr 6:89,642,498...89,819,794
G
MED29
mediator complex subunit 29
decreases expression
EXP
alpha phellandrene results in decreased expression of MED29 mRNA
CTD
PMID:25075043
NCBI chr19:39,391,378...39,400,641
Ensembl chr19:39,391,303...39,400,641
G
MED31
mediator complex subunit 31
increases expression
EXP
alpha phellandrene results in increased expression of MED31 mRNA
CTD
PMID:25075043
NCBI chr17:6,643,311...6,651,605
Ensembl chr17:6,643,311...6,651,634
G
MGARP
mitochondria localized glutamic acid rich protein
increases expression
EXP
alpha phellandrene results in increased expression of MGARP mRNA
CTD
PMID:25075043
NCBI chr 4:139,266,165...139,280,225
Ensembl chr 4:139,266,165...139,280,225
G
MGAT2
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase
decreases expression
EXP
alpha phellandrene results in decreased expression of MGAT2 mRNA
CTD
PMID:25075043
NCBI chr14:49,620,799...49,623,481
Ensembl chr14:49,620,799...49,623,481
G
MGMT
O-6-methylguanine-DNA methyltransferase
decreases expression
ISO
alpha phellandrene results in decreased expression of MGMT protein
CTD
PMID:24861204
NCBI chr10:129,467,241...129,770,983
Ensembl chr10:129,467,190...129,770,983
G
MINDY2
MINDY lysine 48 deubiquitinase 2
increases expression
EXP
alpha phellandrene results in increased expression of MINDY2 mRNA
CTD
PMID:25075043
NCBI chr15:58,771,302...58,861,900
Ensembl chr15:58,771,192...58,861,900
G
MIR17HG
miR-17-92a-1 cluster host gene
decreases expression
EXP
alpha phellandrene results in decreased expression of MIR17HG mRNA
CTD
PMID:25075043
NCBI chr13:91,347,687...91,354,577
Ensembl chr13:91,347,686...91,397,592
G
MIR375
microRNA 375
increases expression
EXP
alpha phellandrene results in increased expression of MIR375 mRNA
CTD
PMID:25075043
NCBI chr 2:219,001,645...219,001,708
Ensembl chr 2:219,001,645...219,001,708
G
MR1
major histocompatibility complex, class I-related
increases expression
EXP
alpha phellandrene results in increased expression of MR1 mRNA
CTD
PMID:25075043
NCBI chr 1:181,033,387...181,061,938
Ensembl chr 1:181,033,374...181,061,938
G
MRPL20
mitochondrial ribosomal protein L20
decreases expression
EXP
alpha phellandrene results in decreased expression of MRPL20 mRNA
CTD
PMID:25075043
NCBI chr 1:1,401,909...1,407,293
Ensembl chr 1:1,401,909...1,407,293
G
MRPL45
mitochondrial ribosomal protein L45
increases expression
EXP
alpha phellandrene results in increased expression of MRPL45 mRNA
CTD
PMID:25075043
NCBI chr17:38,297,168...38,323,211
Ensembl chr17:38,297,023...38,323,217
G
MRTO4
MRT4 homolog, ribosome maturation factor
decreases expression
EXP
alpha phellandrene results in decreased expression of MRTO4 mRNA
CTD
PMID:25075043
NCBI chr 1:19,251,805...19,260,128
Ensembl chr 1:19,251,805...19,260,128
G
MS4A3
membrane spanning 4-domains A3
decreases expression
EXP
alpha phellandrene results in decreased expression of MS4A3 mRNA
CTD
PMID:25075043
NCBI chr11:60,056,665...60,071,115
Ensembl chr11:60,056,587...60,071,115
G
MTOR
mechanistic target of rapamycin kinase
decreases expression
EXP
alpha phellandrene results in decreased expression of MTOR protein
CTD
PMID:25649747
NCBI chr 1:11,106,535...11,262,551
Ensembl chr 1:11,106,535...11,262,556
G
MTX3
metaxin 3
decreases expression
EXP
alpha phellandrene results in decreased expression of MTX3 mRNA
CTD
PMID:25075043
NCBI chr 5:79,976,716...79,991,262
Ensembl chr 5:79,976,716...79,991,262
G
MUC13
mucin 13, cell surface associated
decreases expression
EXP
alpha phellandrene results in decreased expression of MUC13 mRNA
CTD
PMID:25075043
NCBI chr 3:124,905,442...124,934,751
Ensembl chr 3:124,905,442...124,953,819
G
MX2
MX dynamin like GTPase 2
increases expression
EXP
alpha phellandrene results in increased expression of MX2 mRNA
CTD
PMID:25075043
NCBI chr21:41,362,027...41,409,393
Ensembl chr21:41,361,999...41,409,393
G
MXD1
MAX dimerization protein 1
increases expression
EXP
alpha phellandrene results in increased expression of MXD1 mRNA
CTD
PMID:25075043
NCBI chr 2:69,915,109...69,942,945
Ensembl chr 2:69,897,688...69,942,945
G
MYADM
myeloid associated differentiation marker
increases expression
EXP
alpha phellandrene results in increased expression of MYADM mRNA
CTD
PMID:25075043
NCBI chr19:53,865,628...53,876,435
Ensembl chr19:53,864,763...53,878,125
G
MYBBP1A
MYB binding protein 1a
decreases expression
EXP
alpha phellandrene results in decreased expression of MYBBP1A mRNA
CTD
PMID:25075043
NCBI chr17:4,538,904...4,555,384
Ensembl chr17:4,538,897...4,555,386
G
MYO9A
myosin IXA
increases expression
EXP
alpha phellandrene results in increased expression of MYO9A mRNA
CTD
PMID:25075043
NCBI chr15:71,822,291...72,118,600
Ensembl chr15:71,822,291...72,118,577
G
NAMPT
nicotinamide phosphoribosyltransferase
increases expression
EXP
alpha phellandrene results in increased expression of NAMPT mRNA
CTD
PMID:25075043
NCBI chr 7:106,248,298...106,285,888
Ensembl chr 7:106,248,298...106,285,966
G
NAT10
N-acetyltransferase 10
decreases expression
EXP
alpha phellandrene results in decreased expression of NAT10 mRNA
CTD
PMID:25075043
NCBI chr11:34,105,629...34,146,908
Ensembl chr11:34,105,617...34,147,670
G
NDRG2
NDRG family member 2
increases expression
EXP
alpha phellandrene results in increased expression of NDRG2 mRNA
CTD
PMID:25075043
NCBI chr14:21,016,763...21,070,872
Ensembl chr14:21,016,763...21,070,872
G
NFIL3
nuclear factor, interleukin 3 regulated
increases expression
EXP
alpha phellandrene results in increased expression of NFIL3 mRNA
CTD
PMID:25075043
NCBI chr 9:91,409,045...91,483,497
Ensembl chr 9:91,408,748...91,424,626
G
NFKBIA
NFKB inhibitor alpha
increases expression
EXP
alpha phellandrene results in increased expression of NFKBIA mRNA
CTD
PMID:25075043
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
G
NHP2
NHP2 ribonucleoprotein
decreases expression
EXP
alpha phellandrene results in decreased expression of NHP2 mRNA
CTD
PMID:25075043
NCBI chr 5:178,149,463...178,153,885
Ensembl chr 5:178,149,463...178,153,894
G
NOL10
nucleolar protein 10
decreases expression
EXP
alpha phellandrene results in decreased expression of NOL10 mRNA
CTD
PMID:25075043
NCBI chr 2:10,570,754...10,689,975
Ensembl chr 2:10,562,347...10,689,987
G
NOL8
nucleolar protein 8
decreases expression
EXP
alpha phellandrene results in decreased expression of NOL8 mRNA
CTD
PMID:25075043
NCBI chr 9:92,297,358...92,325,350
Ensembl chr 9:92,297,358...92,325,636
G
NOLC1
nucleolar and coiled-body phosphoprotein 1
decreases expression
EXP
alpha phellandrene results in decreased expression of NOLC1 mRNA
CTD
PMID:25075043
NCBI chr10:102,152,389...102,163,870
Ensembl chr10:102,152,176...102,163,871
G
NOP2
NOP2 nucleolar protein
decreases expression
EXP
alpha phellandrene results in decreased expression of NOP2 mRNA
CTD
PMID:25075043
NCBI chr12:6,556,871...6,568,291
Ensembl chr12:6,556,863...6,568,691
G
NOP56
NOP56 ribonucleoprotein
decreases expression
EXP
alpha phellandrene results in decreased expression of NOP56 mRNA
CTD
PMID:25075043
NCBI chr20:2,652,632...2,658,393
Ensembl chr20:2,652,593...2,658,393
G
NOS2
nitric oxide synthase 2
increases expression
EXP
alpha phellandrene results in increased expression of NOS2 mRNA
CTD
PMID:25075043
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
NXT2
nuclear transport factor 2 like export factor 2
increases expression
EXP
alpha phellandrene results in increased expression of NXT2 mRNA
CTD
PMID:25075043
NCBI chr X:109,535,824...109,544,698
Ensembl chr X:109,535,781...109,544,698
G
OAS1
2'-5'-oligoadenylate synthetase 1
increases expression
EXP
alpha phellandrene results in increased expression of OAS1A mRNA; alpha phellandrene results in increased expression of OAS1B mRNA
CTD
PMID:25075043
NCBI chr12:112,906,962...112,933,219
Ensembl chr12:112,905,856...112,933,219
G
OAS3
2'-5'-oligoadenylate synthetase 3
increases expression
EXP
alpha phellandrene results in increased expression of OAS3 mRNA
CTD
PMID:25075043
NCBI chr12:112,938,474...112,973,251
Ensembl chr12:112,938,051...112,976,460
G
OSBPL9
oxysterol binding protein like 9
increases expression
EXP
alpha phellandrene results in increased expression of OSBPL9 mRNA
CTD
PMID:25075043
NCBI chr 1:51,518,272...51,789,219
Ensembl chr 1:51,577,179...51,798,427
G
PABIR2
PABIR family member 2
increases expression
EXP
alpha phellandrene results in increased expression of PABIR2 mRNA
CTD
PMID:25075043
NCBI chr X:134,769,566...134,797,205
Ensembl chr X:134,769,566...134,797,232
G
PARP14
poly(ADP-ribose) polymerase family member 14
increases expression
EXP
alpha phellandrene results in increased expression of PARP14 mRNA
CTD
PMID:25075043
NCBI chr 3:122,680,839...122,730,840
Ensembl chr 3:122,680,839...122,730,840
G
PCYOX1L
prenylcysteine oxidase 1 like
decreases expression
EXP
alpha phellandrene results in decreased expression of PCYOX1L mRNA
CTD
PMID:25075043
NCBI chr 5:149,358,046...149,369,653
Ensembl chr 5:149,358,037...149,369,653
G
PDE3B
phosphodiesterase 3B
increases expression
EXP
alpha phellandrene results in increased expression of PDE3B mRNA
CTD
PMID:25075043
NCBI chr11:14,643,804...14,899,321
Ensembl chr11:14,643,804...14,872,044
G
PHOSPHO1
phosphoethanolamine/phosphocholine phosphatase 1
increases expression
EXP
alpha phellandrene results in increased expression of PHOSPHO1 mRNA
CTD
PMID:25075043
NCBI chr17:49,223,366...49,230,787
Ensembl chr17:49,223,366...49,230,787
G
PIK3CB
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
increases expression
EXP
alpha phellandrene results in increased expression of PIK3CB mRNA
CTD
PMID:25075043
NCBI chr 3:138,652,698...138,834,928
Ensembl chr 3:138,652,336...138,834,928
G
PLD4
phospholipase D family member 4
increases expression
EXP
alpha phellandrene results in increased expression of PLD4 mRNA
CTD
PMID:25075043
NCBI chr14:104,924,879...104,937,785
Ensembl chr14:104,924,713...104,937,761
G
PLXDC1
plexin domain containing 1
increases expression
EXP
alpha phellandrene results in increased expression of PLXDC1 mRNA
CTD
PMID:25075043
NCBI chr17:39,063,313...39,152,967
Ensembl chr17:39,063,313...39,154,394
G
PNRC2
proline rich nuclear receptor coactivator 2
increases expression
EXP
alpha phellandrene results in increased expression of PNRC2 mRNA
CTD
PMID:25075043
NCBI chr 1:23,959,164...23,963,462
Ensembl chr 1:23,956,839...23,963,462
G
POLR1B
RNA polymerase I subunit B
decreases expression
EXP
alpha phellandrene results in decreased expression of POLR1B mRNA
CTD
PMID:25075043
NCBI chr 2:112,542,036...112,579,818
Ensembl chr 2:112,541,915...112,579,818
G
POP1
POP1 homolog, ribonuclease P/MRP subunit
decreases expression
EXP
alpha phellandrene results in decreased expression of POP1 mRNA
CTD
PMID:25075043
NCBI chr 8:98,117,293...98,159,835
Ensembl chr 8:98,117,293...98,159,835
G
PPAN
peter pan homolog
decreases expression
EXP
alpha phellandrene results in decreased expression of PPAN mRNA
CTD
PMID:25075043
NCBI chr19:10,106,223...10,112,012
Ensembl chr19:10,106,362...10,112,012
G
PPAT
phosphoribosyl pyrophosphate amidotransferase
decreases expression
EXP
alpha phellandrene results in decreased expression of PPAT mRNA
CTD
PMID:25075043
NCBI chr 4:56,393,362...56,435,615
Ensembl chr 4:56,393,362...56,435,615
G
PPM1K
protein phosphatase, Mg2+/Mn2+ dependent 1K
increases expression
EXP
alpha phellandrene results in increased expression of PPM1K mRNA
CTD
PMID:25075043
NCBI chr 4:88,257,620...88,284,561
Ensembl chr 4:88,257,620...88,284,769
G
PPP2R5C
protein phosphatase 2 regulatory subunit B'gamma
increases expression
EXP
alpha phellandrene results in increased expression of PPP2R5C mRNA
CTD
PMID:25075043
NCBI chr14:101,760,573...101,927,992
Ensembl chr14:101,761,709...101,927,989
G
PPRC1
PPARG related coactivator 1
decreases expression
EXP
alpha phellandrene results in decreased expression of PPRC1 mRNA
CTD
PMID:25075043
NCBI chr10:102,119,889...102,150,333
Ensembl chr10:102,132,994...102,150,333
G
PRKDC
protein kinase, DNA-activated, catalytic subunit
decreases expression
ISO
alpha phellandrene results in decreased expression of PRKDC protein
CTD
PMID:24861204
NCBI chr 8:47,773,111...47,960,136
Ensembl chr 8:47,773,111...47,960,178
G
PRSS1
serine protease 1
decreases expression
EXP
alpha phellandrene results in decreased expression of TRY10 mRNA
CTD
PMID:25075043
NCBI chr 7:142,749,472...142,753,072
Ensembl chr 7:142,749,468...142,753,072
G
PTBP3
polypyrimidine tract binding protein 3
increases expression
EXP
alpha phellandrene results in increased expression of PTBP3 mRNA
CTD
PMID:25075043
NCBI chr 9:112,217,715...112,379,882
Ensembl chr 9:112,217,716...112,333,664
G
PTPMT1
protein tyrosine phosphatase mitochondrial 1
decreases expression
EXP
alpha phellandrene results in decreased expression of PTPMT1 mRNA
CTD
PMID:25075043
NCBI chr11:47,565,599...47,573,461
Ensembl chr11:47,565,430...47,573,461
G
PTPN7
protein tyrosine phosphatase non-receptor type 7
decreases expression
EXP
alpha phellandrene results in decreased expression of PTPN7 mRNA
CTD
PMID:25075043
NCBI chr 1:202,147,013...202,161,588
Ensembl chr 1:202,147,012...202,161,588
G
PUS7
pseudouridine synthase 7
decreases expression
EXP
alpha phellandrene results in decreased expression of PUS7 mRNA
CTD
PMID:25075043
NCBI chr 7:105,456,501...105,522,271
Ensembl chr 7:105,439,661...105,522,271
G
PUS7L
pseudouridine synthase 7 like
decreases expression
EXP
alpha phellandrene results in decreased expression of PUS7L mRNA
CTD
PMID:25075043
NCBI chr12:43,718,992...43,758,790
Ensembl chr12:43,718,992...43,758,793
G
RAD51C
RAD51 paralog C
increases expression
EXP
alpha phellandrene results in increased expression of RAD51C mRNA
CTD
PMID:25075043
NCBI chr17:58,692,573...58,735,611
Ensembl chr17:58,692,573...58,735,611
G
RAP2B
RAP2B, member of RAS oncogene family
increases expression
EXP
alpha phellandrene results in increased expression of RAP2B mRNA
CTD
PMID:25075043
NCBI chr 3:153,162,226...153,170,627
Ensembl chr 3:153,162,226...153,170,627
G
RBM12B
RNA binding motif protein 12B
decreases expression
EXP
alpha phellandrene results in decreased expression of RBM12B2 mRNA
CTD
PMID:25075043
NCBI chr 8:93,728,155...93,741,009
Ensembl chr 8:93,728,155...93,741,017
G
RBPJ
recombination signal binding protein for immunoglobulin kappa J region
increases expression
EXP
alpha phellandrene results in increased expression of RBPJ mRNA
CTD
PMID:25075043
NCBI chr 4:26,105,449...26,435,131
Ensembl chr 4:26,163,455...26,435,131
G
RCL1
RNA terminal phosphate cyclase like 1
decreases expression
EXP
alpha phellandrene results in decreased expression of RCL1 mRNA
CTD
PMID:25075043
NCBI chr 9:4,792,944...4,861,066
Ensembl chr 9:4,792,944...4,885,917
G
RHOBTB2
Rho related BTB domain containing 2
increases expression
EXP
alpha phellandrene results in increased expression of RHOBTB2 mRNA
CTD
PMID:25075043
NCBI chr 8:22,950,813...23,020,199
Ensembl chr 8:22,987,417...23,020,509
G
RIGI
RNA sensor RIG-I
increases expression
EXP
alpha phellandrene results in increased expression of RIGI mRNA
CTD
PMID:25075043
NCBI chr 9:32,455,302...32,526,196
Ensembl chr 9:32,455,302...32,526,348
G
RNF141
ring finger protein 141
increases expression
EXP
alpha phellandrene results in increased expression of RNF141 mRNA
CTD
PMID:25075043
NCBI chr11:10,511,673...10,541,187
Ensembl chr11:10,511,673...10,541,230
G
RNF19B
ring finger protein 19B
increases expression
EXP
alpha phellandrene results in increased expression of RNF19B mRNA
CTD
PMID:25075043
NCBI chr 1:32,929,036...32,964,809
Ensembl chr 1:32,936,445...32,964,809
G
RP2
RP2 activator of ARL3 GTPase
increases expression
EXP
alpha phellandrene results in increased expression of RP2 mRNA
CTD
PMID:25075043
NCBI chr X:46,837,043...46,882,358
Ensembl chr X:46,837,043...46,882,358
G
RPP14
ribonuclease P/MRP subunit p14
decreases expression
EXP
alpha phellandrene results in decreased expression of RPP14 mRNA
CTD
PMID:25075043
NCBI chr 3:58,306,245...58,320,193
Ensembl chr 3:58,306,245...58,324,695
G
RPP38
ribonuclease P/MRP subunit p38
decreases expression
EXP
alpha phellandrene results in decreased expression of RPP38 mRNA
CTD
PMID:25075043
NCBI chr10:15,097,355...15,104,257
Ensembl chr10:15,097,180...15,139,818
G
RPS12
ribosomal protein S12
decreases expression
EXP
alpha phellandrene results in decreased expression of RPS12 mRNA
CTD
PMID:25075043
NCBI chr 6:132,814,569...132,817,564
Ensembl chr 6:132,814,569...132,817,564
G
RRAS
RAS related
increases expression
EXP
alpha phellandrene results in increased expression of RRAS mRNA
CTD
PMID:25075043
NCBI chr19:49,635,292...49,640,143
Ensembl chr19:49,635,292...49,640,143
G
RRP12
ribosomal RNA processing 12 homolog
decreases expression
EXP
alpha phellandrene results in decreased expression of RRP12 mRNA
CTD
PMID:25075043
NCBI chr10:97,356,357...97,401,370
Ensembl chr10:97,356,357...97,426,076
G
RRP15
ribosomal RNA processing 15 homolog
decreases expression
EXP
alpha phellandrene results in decreased expression of RRP15 mRNA
CTD
PMID:25075043
NCBI chr 1:218,285,293...218,337,983
Ensembl chr 1:218,285,293...218,337,983
G
RSAD2
radical S-adenosyl methionine domain containing 2
increases expression
EXP
alpha phellandrene results in increased expression of RSAD2 mRNA
CTD
PMID:25075043
NCBI chr 2:6,865,885...6,898,239
Ensembl chr 2:6,865,557...6,898,239
G
RTL1
retrotransposon Gag like 1
decreases expression
EXP
alpha phellandrene results in decreased expression of RTL1 mRNA
CTD
PMID:25075043
NCBI chr14:100,879,753...100,903,722
Ensembl chr14:100,879,753...100,903,722
G
RTL8A
retrotransposon Gag like 8A
increases expression
EXP
alpha phellandrene results in increased expression of RTL8A mRNA
CTD
PMID:25075043
NCBI chr X:135,050,932...135,052,135
Ensembl chr X:135,050,932...135,052,196
G
RTP4
receptor transporter protein 4
increases expression
EXP
alpha phellandrene results in increased expression of RTP4 mRNA
CTD
PMID:25075043
NCBI chr 3:187,368,385...187,372,076
Ensembl chr 3:187,368,385...187,372,076
G
RUBCNL
rubicon like autophagy enhancer
increases expression
EXP
alpha phellandrene results in increased expression of RUBCNL mRNA
CTD
PMID:25075043
NCBI chr13:46,334,681...46,390,042
Ensembl chr13:46,334,681...46,438,190
G
SAMHD1
SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1
increases expression
EXP
alpha phellandrene results in increased expression of SAMHD1 mRNA
CTD
PMID:25075043
NCBI chr20:36,889,773...36,951,708
Ensembl chr20:36,890,229...36,951,893
G
SAT1
spermidine/spermine N1-acetyltransferase 1
increases expression
EXP
alpha phellandrene results in increased expression of SAT1 mRNA
CTD
PMID:25075043
NCBI chr X:23,783,173...23,786,210
Ensembl chr X:23,783,173...23,786,210
G
SDAD1
SDA1 domain containing 1
decreases expression
EXP
alpha phellandrene results in decreased expression of SDAD1 mRNA
CTD
PMID:25075043
NCBI chr 4:75,949,915...75,990,945
Ensembl chr 4:75,940,950...75,990,962
G
SEC14L1
SEC14 like lipid binding 1
increases expression
EXP
alpha phellandrene results in increased expression of SEC14L1 mRNA
CTD
PMID:25075043
NCBI chr17:77,088,685...77,217,101
Ensembl chr17:77,088,749...77,217,101
G
SELENBP1
selenium binding protein 1
increases expression
EXP
alpha phellandrene results in increased expression of SELENBP1 mRNA; alpha phellandrene results in increased expression of SELENBP2 mRNA
CTD
PMID:25075043
NCBI chr 1:151,364,304...151,372,705
Ensembl chr 1:151,364,304...151,372,707
G
SEMA3C
semaphorin 3C
decreases expression
EXP
alpha phellandrene results in decreased expression of SEMA3C mRNA
CTD
PMID:25075043
NCBI chr 7:80,742,538...80,922,389
Ensembl chr 7:80,742,538...80,922,359
G
SENP2
SUMO specific peptidase 2
decreases expression
EXP
alpha phellandrene results in decreased expression of SENP2 mRNA
CTD
PMID:25075043
NCBI chr 3:185,586,295...185,633,551
Ensembl chr 3:185,582,496...185,633,551
G
SEPTIN8
septin 8
increases expression
EXP
alpha phellandrene results in increased expression of SEPT8 mRNA
CTD
PMID:25075043
NCBI chr 5:132,750,819...132,780,083
Ensembl chr 5:132,750,819...132,807,241
G
SERTAD3
SERTA domain containing 3
increases expression
EXP
alpha phellandrene results in increased expression of SERTAD3 mRNA
CTD
PMID:25075043
NCBI chr19:40,440,844...40,444,335
Ensembl chr19:40,440,844...40,444,335
G
SET
SET nuclear proto-oncogene
decreases expression
EXP
alpha phellandrene results in decreased expression of SET mRNA
CTD
PMID:25075043
NCBI chr 9:128,683,424...128,696,396
Ensembl chr 9:128,683,424...128,696,400
G
SFN
stratifin
increases expression
ISO
alpha phellandrene results in increased expression of SFN protein
CTD
PMID:24861204
NCBI chr 1:26,863,149...26,864,456
Ensembl chr 1:26,863,149...26,864,456
G
SGF29
SAGA complex associated factor 29
decreases expression
EXP
alpha phellandrene results in decreased expression of SGF29 mRNA
CTD
PMID:25075043
NCBI chr16:28,553,920...28,591,790
Ensembl chr16:28,553,915...28,591,790
G
SGO2
shugoshin 2
increases expression
EXP
alpha phellandrene results in increased expression of SGO2A mRNA
CTD
PMID:25075043
NCBI chr 2:200,526,142...200,584,096
Ensembl chr 2:200,510,008...200,584,096
G
SIGMAR1
sigma non-opioid intracellular receptor 1
decreases expression
EXP
alpha phellandrene results in decreased expression of SIGMAR1 mRNA
CTD
PMID:25075043
NCBI chr 9:34,634,722...34,637,787
Ensembl chr 9:34,634,722...34,637,844
G
SLC1A5
solute carrier family 1 member 5
decreases expression
EXP
alpha phellandrene results in decreased expression of SLC1A5 mRNA
CTD
PMID:25075043
NCBI chr19:46,774,883...46,788,594
Ensembl chr19:46,774,883...46,788,594
G
SLC35B1
solute carrier family 35 member B1
decreases expression
EXP
alpha phellandrene results in decreased expression of SLC35B1 mRNA
CTD
PMID:25075043
NCBI chr17:49,700,943...49,708,197
Ensembl chr17:49,700,934...49,709,014
G
SLC35D1
solute carrier family 35 member D1
decreases expression
EXP
alpha phellandrene results in decreased expression of SLC35D1 mRNA
CTD
PMID:25075043
NCBI chr 1:66,972,976...67,054,148
Ensembl chr 1:66,999,350...67,054,148
G
SLC44A1
solute carrier family 44 member 1
increases expression
EXP
alpha phellandrene results in increased expression of SLC44A1 mRNA
CTD
PMID:25075043
NCBI chr 9:105,244,651...105,438,504
Ensembl chr 9:105,244,622...105,439,171
G
SLC44A3
solute carrier family 44 member 3
increases expression
EXP
alpha phellandrene results in increased expression of SLC44A3 mRNA
CTD
PMID:25075043
NCBI chr 1:94,820,357...94,895,247
Ensembl chr 1:94,820,342...94,895,246
G
SLC7A1
solute carrier family 7 member 1
decreases expression
EXP
alpha phellandrene results in decreased expression of SLC7A1 mRNA
CTD
PMID:25075043
NCBI chr13:29,509,414...29,595,688
Ensembl chr13:29,509,414...29,595,688
G
SLC7A11
solute carrier family 7 member 11
decreases expression
EXP
alpha phellandrene results in decreased expression of SLC7A11 mRNA
CTD
PMID:25075043
NCBI chr 4:138,164,097...138,312,671
Ensembl chr 4:138,164,097...138,242,349
G
SLC7A6
solute carrier family 7 member 6
decreases expression
EXP
alpha phellandrene results in decreased expression of SLC7A6 mRNA
CTD
PMID:25075043
NCBI chr16:68,264,526...68,301,819
Ensembl chr16:68,264,516...68,301,823
G
SLFN5
schlafen family member 5
increases expression
EXP
alpha phellandrene results in increased expression of SLFN4 mRNA; alpha phellandrene results in increased expression of SLFN5 mRNA
CTD
PMID:25075043
NCBI chr17:35,243,072...35,273,655
Ensembl chr17:35,243,071...35,273,655
G
SMIM14
small integral membrane protein 14
increases expression
EXP
alpha phellandrene results in increased expression of SMIM14 mRNA
CTD
PMID:25075043
NCBI chr 4:39,546,336...39,638,865
Ensembl chr 4:39,546,336...39,638,902
G
SMOX
spermine oxidase
increases expression
EXP
alpha phellandrene results in increased expression of SMOX mRNA
CTD
PMID:25075043
NCBI chr20:4,148,828...4,187,727
Ensembl chr20:4,120,980...4,187,747
G
SNHG1
small nucleolar RNA host gene 1
decreases expression
EXP
alpha phellandrene results in decreased expression of SNHG1 mRNA
CTD
PMID:25075043
NCBI chr11:62,851,978...62,855,885
Ensembl chr11:62,851,833...62,856,444
G
SNHG20
small nucleolar RNA host gene 20
decreases expression
EXP
alpha phellandrene results in decreased expression of SNHG20 mRNA
CTD
PMID:25075043
NCBI chr17:77,088,643...77,094,986
Ensembl chr17:77,086,716...77,099,902
G
SNHG5
small nucleolar RNA host gene 5
decreases expression
EXP
alpha phellandrene results in decreased expression of SNHG5 mRNA
CTD
PMID:25075043
NCBI chr 6:85,677,007...85,678,733
Ensembl chr 6:85,644,369...85,678,943
G
SNORA20
small nucleolar RNA, H/ACA box 20
decreases expression
EXP
alpha phellandrene results in decreased expression of SNORA20 mRNA
CTD
PMID:25075043
NCBI chr 6:159,780,250...159,780,381
Ensembl chr 6:159,780,250...159,780,381
G
SNORA21
small nucleolar RNA, H/ACA box 21
decreases expression
EXP
alpha phellandrene results in decreased expression of SNORA21 mRNA
CTD
PMID:25075043
NCBI chr17:38,852,863...38,852,995
Ensembl chr17:38,852,863...38,852,994
G
SNORA26
small nucleolar RNA, H/ACA box 26
decreases expression
EXP
alpha phellandrene results in decreased expression of SNORA26 mRNA
CTD
PMID:25075043
NCBI chr 4:52,713,249...52,713,370
Ensembl chr 4:52,713,249...52,713,370
G
SNORA3A
small nucleolar RNA, H/ACA box 3A
decreases expression
EXP
alpha phellandrene results in decreased expression of SNORA3 mRNA
CTD
PMID:25075043
NCBI chr11:8,684,227...8,684,356
Ensembl chr11:8,684,227...8,684,356
G
SNORA44
small nucleolar RNA, H/ACA box 44
decreases expression
EXP
alpha phellandrene results in decreased expression of SNORA44 mRNA
CTD
PMID:25075043
NCBI chr 1:28,580,381...28,580,512
Ensembl chr 1:28,580,381...28,580,512
G
SNORA61
small nucleolar RNA, H/ACA box 61
decreases expression
EXP
alpha phellandrene results in decreased expression of SNORA61 mRNA
CTD
PMID:25075043
NCBI chr 1:28,579,764...28,579,893
Ensembl chr 1:28,579,764...28,579,893
G
SNORA73A
small nucleolar RNA, H/ACA box 73A
decreases expression
EXP
alpha phellandrene results in decreased expression of SNORA73A mRNA
CTD
PMID:25075043
NCBI chr 1:28,507,365...28,507,571
Ensembl chr 1:28,507,366...28,507,571
G
SNORA73B
small nucleolar RNA, H/ACA box 73B
decreases expression
EXP
alpha phellandrene results in decreased expression of SNORA73B mRNA
CTD
PMID:25075043
NCBI chr 1:28,508,558...28,508,762
Ensembl chr 1:28,508,559...28,508,762
G
SNORA75
small nucleolar RNA, H/ACA box 75
decreases expression
EXP
alpha phellandrene results in decreased expression of SNORA75 mRNA
CTD
PMID:25075043
NCBI chr 2:231,455,800...231,455,936
Ensembl chr 2:231,455,800...231,455,936
G
SNORA7A
small nucleolar RNA, H/ACA box 7A
decreases expression
EXP
alpha phellandrene results in decreased expression of SNORA7A mRNA
CTD
PMID:25075043
NCBI chr 3:12,840,312...12,840,450
Ensembl chr 3:12,840,312...12,840,450
G
SNORD22
small nucleolar RNA, C/D box 22
decreases expression
EXP
alpha phellandrene results in decreased expression of SNORD22 mRNA
CTD
PMID:25075043
NCBI chr11:62,852,910...62,853,035
Ensembl chr11:62,852,910...62,853,035
G
SNORD34
small nucleolar RNA, C/D box 34
decreases expression
EXP
alpha phellandrene results in decreased expression of SNORD34 mRNA
CTD
PMID:25075043
NCBI chr19:49,490,907...49,490,972
Ensembl chr19:49,490,904...49,490,974
G
SNORD47
small nucleolar RNA, C/D box 47
decreases expression
EXP
alpha phellandrene results in decreased expression of SNORD47 mRNA
CTD
PMID:25075043
NCBI chr 1:173,864,369...173,864,445
G
SNORD52
small nucleolar RNA, C/D box 52
decreases expression
EXP
alpha phellandrene results in decreased expression of SNORD52 mRNA
CTD
PMID:25075043
NCBI chr 6:31,837,076...31,837,139
Ensembl chr 6:31,837,076...31,837,142
G
SNORD68
small nucleolar RNA, C/D box 68
decreases expression
EXP
alpha phellandrene results in decreased expression of SNORD68 mRNA
CTD
PMID:25075043
NCBI chr16:89,561,430...89,561,501
Ensembl chr16:89,561,434...89,561,517
G
SNORD82
small nucleolar RNA, C/D box 82
decreases expression
EXP
alpha phellandrene results in decreased expression of SNORD82 mRNA
CTD
PMID:25075043
NCBI chr 2:231,460,368...231,460,442
Ensembl chr 2:231,460,371...231,460,440
G
SNORD87
small nucleolar RNA, C/D box 87
decreases expression
EXP
alpha phellandrene results in decreased expression of SNORD87 mRNA
CTD
PMID:25075043
NCBI chr 8:66,922,474...66,922,549
Ensembl chr 8:66,922,467...66,922,555
G
SNORD95
small nucleolar RNA, C/D box 95
decreases expression
EXP
alpha phellandrene results in decreased expression of SNORD95 mRNA
CTD
PMID:25075043
NCBI chr 5:181,243,314...181,243,376
Ensembl chr 5:181,243,312...181,243,379
G
SNORD96A
small nucleolar RNA, C/D box 96A
decreases expression
EXP
alpha phellandrene results in decreased expression of SNORD96A mRNA
CTD
PMID:25075043
NCBI chr 5:181,241,818...181,241,889
Ensembl chr 5:181,241,814...181,241,892
G
SNRPD2
small nuclear ribonucleoprotein D2 polypeptide
decreases expression
EXP
alpha phellandrene results in decreased expression of SNRPD2 mRNA
CTD
PMID:25075043
NCBI chr19:45,687,454...45,692,316
Ensembl chr19:45,687,460...45,692,569
G
SP100
SP100 nuclear antigen
increases expression
EXP
alpha phellandrene results in increased expression of SP100 mRNA
CTD
PMID:25075043
NCBI chr 2:230,416,201...230,545,606
Ensembl chr 2:230,415,942...230,545,606
G
SP140
SP140 nuclear body protein
increases expression
EXP
alpha phellandrene results in increased expression of SP140 mRNA
CTD
PMID:25075043
NCBI chr 2:230,186,151...230,316,571
Ensembl chr 2:230,203,110...230,313,215
G
SPC25
SPC25 component of NDC80 kinetochore complex
increases expression
EXP
alpha phellandrene results in increased expression of SPC25 mRNA
CTD
PMID:25075043
NCBI chr 2:168,861,521...168,890,430
Ensembl chr 2:168,834,132...168,913,371
G
SPRED3
sprouty related EVH1 domain containing 3
increases expression
EXP
alpha phellandrene results in increased expression of SPRED3 mRNA
CTD
PMID:25075043
NCBI chr19:38,388,697...38,399,587
Ensembl chr19:38,388,421...38,399,587
G
SRI
sorcin
increases expression
EXP
alpha phellandrene results in increased expression of SRI mRNA
CTD
PMID:25075043
NCBI chr 7:88,205,115...88,226,976
Ensembl chr 7:88,205,115...88,226,993
G
SRM
spermidine synthase
decreases expression
EXP
alpha phellandrene results in decreased expression of SRM mRNA
CTD
PMID:25075043
NCBI chr 1:11,054,589...11,060,018
Ensembl chr 1:11,054,584...11,060,020
G
SRR
serine racemase
increases expression
EXP
alpha phellandrene results in increased expression of SRR mRNA
CTD
PMID:25075043
NCBI chr17:2,303,378...2,325,264
Ensembl chr17:2,303,383...2,325,260
G
SRSF7
serine and arginine rich splicing factor 7
decreases expression
EXP
alpha phellandrene results in decreased expression of SRSF7 mRNA
CTD
PMID:25075043
NCBI chr 2:38,743,599...38,751,494
Ensembl chr 2:38,743,599...38,751,494
G
SSR4
signal sequence receptor subunit 4
decreases expression
EXP
alpha phellandrene results in decreased expression of SSR4 mRNA
CTD
PMID:25075043
NCBI chr X:153,794,159...153,798,512
Ensembl chr X:153,793,516...153,798,499
G
ST8SIA5
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5
decreases expression
EXP
alpha phellandrene results in decreased expression of ST8SIA5 mRNA
CTD
PMID:25075043
NCBI chr18:46,667,821...46,757,053
Ensembl chr18:46,667,821...46,759,257
G
STARD3NL
STARD3 N-terminal like
increases expression
EXP
alpha phellandrene results in increased expression of STARD3NL mRNA
CTD
PMID:25075043
NCBI chr 7:38,178,245...38,230,669
Ensembl chr 7:38,178,245...38,230,670
G
STARD5
StAR related lipid transfer domain containing 5
increases expression
EXP
alpha phellandrene results in increased expression of STARD5 mRNA
CTD
PMID:25075043
NCBI chr15:81,309,053...81,324,141
Ensembl chr15:81,309,053...81,324,183
G
STAT1
signal transducer and activator of transcription 1
increases expression
EXP
alpha phellandrene results in increased expression of STAT1 mRNA
CTD
PMID:25075043
NCBI chr 2:190,969,149...191,014,171
Ensembl chr 2:190,908,460...191,020,960
G
STAT2
signal transducer and activator of transcription 2
increases expression
EXP
alpha phellandrene results in increased expression of STAT2 mRNA
CTD
PMID:25075043
NCBI chr12:56,341,597...56,360,107
Ensembl chr12:56,341,597...56,360,203
G
SUPV3L1
Suv3 like RNA helicase
decreases expression
EXP
alpha phellandrene results in decreased expression of SUPV3L1 mRNA
CTD
PMID:25075043
NCBI chr10:69,180,234...69,209,093
Ensembl chr10:69,180,234...69,209,099
G
TAF1D
TATA-box binding protein associated factor, RNA polymerase I subunit D
decreases expression
EXP
alpha phellandrene results in decreased expression of TAF1D mRNA
CTD
PMID:25075043
NCBI chr11:93,730,194...93,741,495
Ensembl chr11:93,729,948...93,784,391
G
TBXAS1
thromboxane A synthase 1
decreases expression
EXP
alpha phellandrene results in decreased expression of TBXAS1 mRNA
CTD
PMID:25075043
NCBI chr 7:139,778,242...140,020,293
Ensembl chr 7:139,777,051...140,020,325
G
TCEANC
transcription elongation factor A N-terminal and central domain containing
increases expression
EXP
alpha phellandrene results in increased expression of TCEANC mRNA
CTD
PMID:25075043
NCBI chr X:13,653,141...13,665,409
Ensembl chr X:13,653,112...13,681,964
G
TCP11L2
t-complex 11 like 2
increases expression
EXP
alpha phellandrene results in increased expression of TCP11L2 mRNA
CTD
PMID:25075043
NCBI chr12:106,297,935...106,347,003
Ensembl chr12:106,301,929...106,347,538
G
TCTN3
tectonic family member 3
increases expression
EXP
alpha phellandrene results in increased expression of TCTN3 mRNA
CTD
PMID:25075043
NCBI chr10:95,663,401...95,693,927
Ensembl chr10:95,659,823...95,694,143
G
TDRD7
tudor domain containing 7
increases expression
EXP
alpha phellandrene results in increased expression of TDRD7 mRNA
CTD
PMID:25075043
NCBI chr 9:97,412,096...97,496,125
Ensembl chr 9:97,412,096...97,496,125
G
TEPSIN
TEPSIN adaptor related protein complex 4 accessory protein
decreases expression
EXP
alpha phellandrene results in decreased expression of TEPSIN mRNA
CTD
PMID:25075043
NCBI chr17:81,228,277...81,239,055
Ensembl chr17:81,228,277...81,239,091
G
TESK2
testis associated actin remodelling kinase 2
increases expression
EXP
alpha phellandrene results in increased expression of TESK2 mRNA
CTD
PMID:25075043
NCBI chr 1:45,343,883...45,491,163
Ensembl chr 1:45,343,883...45,491,163
G
TFAP4
transcription factor AP-4
decreases expression
EXP
alpha phellandrene results in decreased expression of TFAP4 mRNA
CTD
PMID:25075043
NCBI chr16:4,257,186...4,273,023
Ensembl chr16:4,257,186...4,273,075
G
THG1L
tRNA-histidine guanylyltransferase 1 like
decreases expression
EXP
alpha phellandrene results in decreased expression of THG1L mRNA
CTD
PMID:25075043
NCBI chr 5:157,731,420...157,741,449
Ensembl chr 5:157,731,420...157,741,449
G
TIMM10
translocase of inner mitochondrial membrane 10
decreases expression
EXP
alpha phellandrene results in decreased expression of TIMM10 mRNA
CTD
PMID:25075043
NCBI chr11:57,528,464...57,530,754
Ensembl chr11:57,528,464...57,530,803
G
TMEM120A
transmembrane protein 120A
decreases expression
EXP
alpha phellandrene results in decreased expression of TMEM120A mRNA
CTD
PMID:25075043
NCBI chr 7:75,986,831...75,994,595
Ensembl chr 7:75,986,831...75,994,656
G
TMEM97
transmembrane protein 97
decreases expression
EXP
alpha phellandrene results in decreased expression of TMEM97 mRNA
CTD
PMID:25075043
NCBI chr17:28,319,200...28,328,685
Ensembl chr17:28,319,200...28,328,685
G
TMSB10
thymosin beta 10
increases expression
EXP
alpha phellandrene results in increased expression of TMSB10 mRNA
CTD
PMID:25075043
NCBI chr 2:84,905,656...84,906,671
Ensembl chr 2:84,905,656...84,906,671
G
TMSB4X
thymosin beta 4 X-linked
increases expression
EXP
alpha phellandrene results in increased expression of TMSB4X mRNA
CTD
PMID:25075043
NCBI chr X:12,975,110...12,977,223
Ensembl chr X:12,975,110...12,977,227
G
TP53
tumor protein p53
increases expression decreases expression affects localization increases phosphorylation
ISO EXP
alpha phellandrene results in increased expression of TRP53 protein modified form alpha phellandrene results in decreased expression of TRP53 protein alpha phellandrene affects the localization of TP53 protein alpha phellandrene results in increased phosphorylation of TRP53 protein
CTD
PMID:24861204 PMID:25649747
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,546
G
TPD52
tumor protein D52
increases expression
EXP
alpha phellandrene results in increased expression of TPD52 mRNA
CTD
PMID:25075043
NCBI chr 8:80,031,082...80,171,564
Ensembl chr 8:80,034,745...80,231,232
G
TPM4
tropomyosin 4
increases expression
EXP
alpha phellandrene results in increased expression of TPM4 mRNA
CTD
PMID:25075043
NCBI chr19:16,067,538...16,103,002
Ensembl chr19:16,067,021...16,103,005
G
TRIM21
tripartite motif containing 21
increases expression
EXP
alpha phellandrene results in increased expression of TRIM21 mRNA
CTD
PMID:25075043
NCBI chr11:4,384,897...4,393,702
Ensembl chr11:4,384,897...4,393,702
G
TRIM22
tripartite motif containing 22
increases expression
EXP
alpha phellandrene results in increased expression of TRIM30A mRNA
CTD
PMID:25075043
NCBI chr11:5,689,790...5,710,863
Ensembl chr11:5,689,610...5,737,089
G
TSPOAP1
TSPO associated protein 1
increases expression
EXP
alpha phellandrene results in increased expression of TSPOAP1 mRNA
CTD
PMID:25075043
NCBI chr17:58,301,231...58,328,795
Ensembl chr17:58,301,228...58,328,795
G
TSR1
TSR1 ribosome maturation factor
decreases expression
EXP
alpha phellandrene results in decreased expression of TSR1 mRNA
CTD
PMID:25075043
NCBI chr17:2,322,396...2,336,457
Ensembl chr17:2,322,396...2,336,657
G
TSTD3
thiosulfate sulfurtransferase like domain containing 3
increases expression
EXP
alpha phellandrene results in increased expression of TSTD3 mRNA
CTD
PMID:25075043
NCBI chr 6:99,521,049...99,587,775
Ensembl chr 6:99,520,976...99,589,899
G
TTC27
tetratricopeptide repeat domain 27
decreases expression
EXP
alpha phellandrene results in decreased expression of TTC27 mRNA
CTD
PMID:25075043
NCBI chr 2:32,628,050...32,821,051
Ensembl chr 2:32,628,032...32,821,051
G
UBASH3A
ubiquitin associated and SH3 domain containing A
decreases expression
EXP
alpha phellandrene results in decreased expression of UBASH3A mRNA
CTD
PMID:25075043
NCBI chr21:42,403,902...42,447,684
Ensembl chr21:42,403,447...42,447,684
G
UBE2H
ubiquitin conjugating enzyme E2 H
increases expression
EXP
alpha phellandrene results in increased expression of UBE2H mRNA
CTD
PMID:25075043
NCBI chr 7:129,830,732...129,952,960
Ensembl chr 7:129,830,732...129,952,960
G
URB2
URB2 ribosome biogenesis homolog
decreases expression
EXP
alpha phellandrene results in decreased expression of URB2 mRNA
CTD
PMID:25075043
NCBI chr 1:229,626,247...229,660,200
Ensembl chr 1:229,626,247...229,660,200
G
USP18
ubiquitin specific peptidase 18
increases expression
EXP
alpha phellandrene results in increased expression of USP18 mRNA
CTD
PMID:25075043
NCBI chr22:18,150,170...18,177,397
Ensembl chr22:18,149,843...18,177,397
G
USP22
ubiquitin specific peptidase 22
increases expression
EXP
alpha phellandrene results in increased expression of USP22 mRNA
CTD
PMID:25075043
NCBI chr17:20,999,596...21,043,419
Ensembl chr17:20,999,596...21,043,760
G
USP36
ubiquitin specific peptidase 36
decreases expression
EXP
alpha phellandrene results in decreased expression of USP36 mRNA
CTD
PMID:25075043
NCBI chr17:78,787,381...78,841,439
Ensembl chr17:78,787,381...78,841,441
G
UTP20
UTP20 small subunit processome component
decreases expression
EXP
alpha phellandrene results in decreased expression of UTP20 mRNA
CTD
PMID:25075043
NCBI chr12:101,280,105...101,386,618
Ensembl chr12:101,280,105...101,386,618
G
WDR12
WD repeat domain 12
decreases expression
EXP
alpha phellandrene results in decreased expression of WDR12 mRNA
CTD
PMID:25075043
NCBI chr 2:202,874,261...202,911,673
Ensembl chr 2:202,874,261...203,014,798
G
WDR3
WD repeat domain 3
decreases expression
EXP
alpha phellandrene results in decreased expression of WDR3 mRNA
CTD
PMID:25075043
NCBI chr 1:117,929,739...117,966,543
Ensembl chr 1:117,929,720...117,966,543
G
WDR74
WD repeat domain 74
decreases expression
EXP
alpha phellandrene results in decreased expression of WDR74 mRNA
CTD
PMID:25075043
NCBI chr11:62,832,905...62,841,809
Ensembl chr11:62,832,342...62,841,809
G
WDR75
WD repeat domain 75
decreases expression
EXP
alpha phellandrene results in decreased expression of WDR75 mRNA
CTD
PMID:25075043
NCBI chr 2:189,441,474...189,475,552
Ensembl chr 2:189,441,446...189,475,552
G
WDSUB1
WD repeat, sterile alpha motif and U-box domain containing 1
increases expression
EXP
alpha phellandrene results in increased expression of WDSUB1 mRNA
CTD
PMID:25075043
NCBI chr 2:159,235,798...159,286,703
Ensembl chr 2:159,235,798...159,286,703
G
WIPI1
WD repeat domain, phosphoinositide interacting 1
increases expression
EXP
alpha phellandrene results in increased expression of WIPI1 mRNA
CTD
PMID:25075043
NCBI chr17:68,421,281...68,457,496
Ensembl chr17:68,420,948...68,457,513
G
XAF1
XIAP associated factor 1
increases expression
EXP
alpha phellandrene results in increased expression of XAF1 mRNA
CTD
PMID:25075043
NCBI chr17:6,755,447...6,775,647
Ensembl chr17:6,755,447...6,775,647
G
YARS2
tyrosyl-tRNA synthetase 2
decreases expression
EXP
alpha phellandrene results in decreased expression of YARS2 mRNA
CTD
PMID:25075043
NCBI chr12:32,746,544...32,755,897
Ensembl chr12:32,727,490...32,755,897
G
ZBP1
Z-DNA binding protein 1
increases expression
EXP
alpha phellandrene results in increased expression of ZBP1 mRNA
CTD
PMID:25075043
NCBI chr20:57,603,852...57,620,426
Ensembl chr20:57,603,846...57,620,576
G
ZFAS1
ZNFX1 antisense RNA 1
decreases expression
EXP
alpha phellandrene results in decreased expression of ZFAS1 mRNA
CTD
PMID:25075043
NCBI chr20:49,278,178...49,289,260
Ensembl chr20:49,277,054...49,299,600
G
ZNF260
zinc finger protein 260
increases expression
EXP
alpha phellandrene results in increased expression of ZFP260 mRNA
CTD
PMID:25075043
NCBI chr19:36,510,687...36,528,271
Ensembl chr19:36,510,687...36,528,271
G
ZNF346
zinc finger protein 346
decreases expression
EXP
alpha phellandrene results in decreased expression of ZFP346 mRNA
CTD
PMID:25075043
NCBI chr 5:177,022,696...177,081,189
Ensembl chr 5:177,022,696...177,081,189
G
ZNF717
zinc finger protein 717
increases expression
EXP
alpha phellandrene results in increased expression of ZFP719 mRNA
CTD
PMID:25075043
NCBI chr 3:75,694,701...75,785,549
Ensembl chr 3:75,678,660...75,785,583
G
ZNF778
zinc finger protein 778
decreases expression
EXP
alpha phellandrene results in decreased expression of ZFP882 mRNA
CTD
PMID:25075043
NCBI chr16:89,217,703...89,237,141
Ensembl chr16:89,217,703...89,237,141
G
ABCB1
ATP binding cassette subfamily B member 1
multiple interactions
EXP
gamma-terpinene inhibits the reaction [ABCB1 protein results in increased uptake of Digoxin]
CTD
PMID:16904803
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
G
AHR
aryl hydrocarbon receptor
multiple interactions
EXP
[4-cymene co-treated with beta-pinene co-treated with gamma-terpinene co-treated with cuminol] results in increased activity of AHR protein; [4-cymene co-treated with gamma-terpinene co-treated with Thymol co-treated with carvacrol] inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]; [4-cymene co-treated with gamma-terpinene co-treated with Thymol co-treated with carvacrol] results in increased activity of AHR protein; [4-cymene co-treated with gamma-terpinene co-treated with Thymol] inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]; [4-cymene co-treated with gamma-terpinene co-treated with Thymol] results in increased activity of AHR protein
CTD
PMID:29191726
NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
G
AR
androgen receptor
multiple interactions
EXP
gamma-terpinene inhibits the reaction [Testosterone results in increased activity of AR protein]
CTD
PMID:31393563
NCBI chr X:67,544,021...67,730,619
Ensembl chr X:67,544,021...67,730,619
G
CTSD
cathepsin D
increases expression
EXP
gamma-terpinene results in increased expression of CTSD mRNA
CTD
PMID:31393563
NCBI chr11:1,752,755...1,763,927
Ensembl chr11:1,752,752...1,764,573
G
CYP4F8
cytochrome P450 family 4 subfamily F member 8
multiple interactions
EXP
gamma-terpinene inhibits the reaction [Testosterone results in increased expression of CYP4F8 mRNA]
CTD
PMID:31393563
NCBI chr19:15,615,218...15,630,639
Ensembl chr19:15,615,218...15,630,639
G
GREB1
growth regulating estrogen receptor binding 1
increases expression
EXP
gamma-terpinene results in increased expression of GREB1 mRNA
CTD
PMID:31393563
NCBI chr 2:11,482,888...11,642,788
Ensembl chr 2:11,482,341...11,642,788
G
PGR
progesterone receptor
increases expression multiple interactions
EXP
gamma-terpinene results in increased expression of PGR mRNA Fulvestrant inhibits the reaction [gamma-terpinene results in increased expression of PGR mRNA]
CTD
PMID:31393563
NCBI chr11:101,029,624...101,129,813
Ensembl chr11:101,029,624...101,129,813
G
SEC14L2
SEC14 like lipid binding 2
multiple interactions
EXP
gamma-terpinene inhibits the reaction [Testosterone results in increased expression of SEC14L2 mRNA]
CTD
PMID:31393563
NCBI chr22:30,397,018...30,425,303
Ensembl chr22:30,396,941...30,425,303
G
AR
androgen receptor
multiple interactions
EXP
Tea Tree Oil inhibits the reaction [Testosterone results in increased activity of AR protein]
CTD
PMID:31393563
NCBI chr X:67,544,021...67,730,619
Ensembl chr X:67,544,021...67,730,619
G
CTSD
cathepsin D
multiple interactions increases expression
EXP
Fulvestrant inhibits the reaction [Tea Tree Oil results in increased expression of CTSD mRNA]
CTD
PMID:31393563
NCBI chr11:1,752,755...1,763,927
Ensembl chr11:1,752,752...1,764,573
G
CYP4F8
cytochrome P450 family 4 subfamily F member 8
multiple interactions
EXP
Tea Tree Oil inhibits the reaction [Testosterone results in increased expression of CYP4F8 mRNA]
CTD
PMID:31393563
NCBI chr19:15,615,218...15,630,639
Ensembl chr19:15,615,218...15,630,639
G
ESR1
estrogen receptor 1
increases activity
EXP
Tea Tree Oil results in increased activity of ESR1 protein
CTD
PMID:31393563
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
G
GREB1
growth regulating estrogen receptor binding 1
multiple interactions increases expression
EXP
Fulvestrant inhibits the reaction [Tea Tree Oil results in increased expression of GREB1 mRNA]
CTD
PMID:31393563
NCBI chr 2:11,482,888...11,642,788
Ensembl chr 2:11,482,341...11,642,788
G
PGR
progesterone receptor
increases expression multiple interactions
EXP
Tea Tree Oil results in increased expression of PGR mRNA Fulvestrant inhibits the reaction [Tea Tree Oil results in increased expression of PGR mRNA]
CTD
PMID:31393563
NCBI chr11:101,029,624...101,129,813
Ensembl chr11:101,029,624...101,129,813
G
SEC14L2
SEC14 like lipid binding 2
multiple interactions
EXP
Tea Tree Oil inhibits the reaction [Testosterone results in increased expression of SEC14L2 mRNA]
CTD
PMID:31393563
NCBI chr22:30,397,018...30,425,303
Ensembl chr22:30,396,941...30,425,303
G
UGT2B28
UDP glucuronosyltransferase family 2 member B28
multiple interactions
EXP
Tea Tree Oil inhibits the reaction [Testosterone results in increased expression of UGT2B28 mRNA]
CTD
PMID:31393563
NCBI chr 4:69,280,475...69,295,050
Ensembl chr 4:69,280,475...69,295,050
G
AKT1
AKT serine/threonine kinase 1
multiple interactions
ISO
zingiberene inhibits the reaction [Isoproterenol results in increased expression of AKT1 mRNA]
CTD
PMID:33242989
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759
G
BAX
BCL2 associated X, apoptosis regulator
multiple interactions
ISO
zingiberene inhibits the reaction [Isoproterenol results in increased expression of BAX protein]
CTD
PMID:33242989
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
G
BCL2
BCL2 apoptosis regulator
multiple interactions
ISO
zingiberene inhibits the reaction [Isoproterenol results in decreased expression of BCL2 protein]
CTD
PMID:33242989
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
G
CASP3
caspase 3
multiple interactions
ISO
zingiberene inhibits the reaction [Isoproterenol results in increased expression of CASP3 protein]
CTD
PMID:33242989
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CAT
catalase
multiple interactions
ISO
zingiberene inhibits the reaction [Isoproterenol results in decreased activity of CAT protein]
CTD
PMID:33242989
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CYCS
cytochrome c, somatic
multiple interactions
ISO
zingiberene inhibits the reaction [Isoproterenol results in increased expression of CYCS protein]
CTD
PMID:33242989
NCBI chr 7:25,118,656...25,125,260
Ensembl chr 7:25,118,656...25,125,260
G
IL1B
interleukin 1 beta
multiple interactions
ISO
zingiberene inhibits the reaction [Isoproterenol results in increased expression of IL1B mRNA]; zingiberene inhibits the reaction [Isoproterenol results in increased expression of IL1B protein]
CTD
PMID:33242989
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL6
interleukin 6
multiple interactions
ISO
zingiberene inhibits the reaction [Isoproterenol results in increased expression of IL6 mRNA]; zingiberene inhibits the reaction [Isoproterenol results in increased expression of IL6 protein]
CTD
PMID:33242989
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
MMP2
matrix metallopeptidase 2
multiple interactions
ISO
zingiberene inhibits the reaction [Isoproterenol results in increased expression of MMP2 mRNA]
CTD
PMID:33242989
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
G
MMP9
matrix metallopeptidase 9
multiple interactions
ISO
zingiberene inhibits the reaction [Isoproterenol results in increased expression of MMP9 mRNA]
CTD
PMID:33242989
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
NOS2
nitric oxide synthase 2
multiple interactions
ISO
zingiberene inhibits the reaction [Isoproterenol results in increased expression of NOS2 mRNA]
CTD
PMID:33242989
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
NOS3
nitric oxide synthase 3
multiple interactions
ISO
zingiberene inhibits the reaction [Isoproterenol results in increased expression of NOS3 mRNA]
CTD
PMID:33242989
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
G
RELA
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
zingiberene inhibits the reaction [Isoproterenol results in increased expression of RELA protein]
CTD
PMID:33242989
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
G
TNF
tumor necrosis factor
multiple interactions
ISO
zingiberene inhibits the reaction [Isoproterenol results in increased expression of TNF mRNA]; zingiberene inhibits the reaction [Isoproterenol results in increased expression of TNF protein]
CTD
PMID:33242989
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TNNI3
troponin I3, cardiac type
multiple interactions
ISO
zingiberene inhibits the reaction [Isoproterenol results in increased expression of TNNI3 mRNA]; zingiberene inhibits the reaction [Isoproterenol results in increased expression of TNNI3 protein]
CTD
PMID:33242989
NCBI chr19:55,151,767...55,157,732
Ensembl chr19:55,151,767...55,157,773
G
VEGFA
vascular endothelial growth factor A
multiple interactions
ISO
zingiberene inhibits the reaction [Isoproterenol results in increased expression of VEGFA mRNA]
CTD
PMID:33242989
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all